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Abstract 
Plasmids are extrachromosomal DNA elements that often carry beneficial 
phenotypes for the bacterial host. Incompatibility type A/C (IncA/C) plasmids are large 
(~100 ~ 200 kilobases (kb)), conjugative plasmids that are carried by Gram-negative 
bacteria. IncA/C plasmids often carry numerous genes that confer resistance to 
antimicrobials and have been isolated from many types of bacteria that pose significant 
risks in both human and animal medicine.  
Although IncA/C plasmids have been described in the literature for many years, 
little is known about their basic biology. For the past decade, many fully sequenced 
IncA/C variants have been described. There has been a lack of work concerning core 
functions of these plasmids, such as, replication, conjugative transfer and maintenance. 
This dissertation focuses on how these plasmids are regulated on a transcriptional level.  
 We used pAR060302, a prototypical IncA/C plasmid, to conduct several 
experiments investigating exactly what genes are transcribed and how different 
conditions affect their transcriptional landscape. RNA-Seq was used to understand how 
antimicrobial exposure can affect the way genes are expressed on IncA/C plasmids. We 
found that, under the conditions we tested, antimicrobials have little effect on the 
transcription of genes on pAR060302. However, this initial study was the first to explore 
genes carried IncA/C plasmids in terms of their expression. 
 Further RNA-Seq experiments were carried out in several different bacterial 
genera all carrying the same IncA/C plasmid, pAR060302. These experiments attempted 
to characterize how a broad host-range plasmid, such as IncA/C, might be differentially 
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regulated in different hosts. We found that only subtle changes occur in the expression of 
plasmid genes. Carriage of IncA/C plasmids was found to have diverse effects on 
chromosomal gene expression. Genes involved in 2-carbon metabolism in Escherichia 
coli are up-regulated due to plasmid carriage. Our results suggest that plasmid encoded 
factors might serve varying levels of importance depending on the host chromosomal 
background. 
 Experiments were carried out on E. coli carrying plasmids with mutations in a 
group of predicted transcriptional regulators to determine their function. We identified 
the positive regulators of conjugative transfer in IncA/C plasmids, acaD and acaC. We 
also found a repressor of transfer, acr2, which encodes an H-NS-like protein. We further 
show that acr2 might regulate genes beyond those that are involved in conjugative 
transfer. 
 This dissertation builds on our understanding on what mechanisms are important 
for the maintenance of large plasmids in Gram-negative bacteria. Understanding how 
plasmids might specifically tune host metabolism to improve competitive fitness would 
impact what evolutionary processes were involved in their emergence. Characterization 
of regulatory networks that govern core plasmid processes, such as conjugation, might 
assist in the development of new models of how these plasmids disseminate throughout 
bacterial populations.  
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Chapter 1 
General Introduction2 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
2 A version of this chapter was published in: 
T. J. Johnson and Kevin S. Lang. IncA/C plasmids: An emerging threat? Mobile Genetic Elements. 2012. 
2:55-58 
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 Since the discovery of the first multidrug-resistant Shigella strains in 1955, 
plasmids encoding multidrug resistance have been extensively studied and appreciated 
for their diversity and plasticity (1). Incompatibility type A/C (IncA/C) plasmids are just 
one of many Inc types. They were first described more than 4 decades ago, but are only 
now being intensively studied. IncA/C plasmids were first identified among multidrug 
resistant Aeromonas hydrophila and Vibrio spp. causing disease in cultured fish in the 
1970s, where it was hypothesized that such plasmids emerged in response to the common 
practice of therapeutic antibiotic treatment in response to disease (2, 3). These are the 
first reports of IncA/C plasmids being associated with animal agriculture practices. 
  
 In the 1990s, the plasmid-encoded β-lactamase gene, blaCMY-2 was identified among 
Klebsiella pneumoniae (4), and several reports in the early 2000s identified blaCMY-2 on a 
conjugative element in Escherichia coli and Salmonella enterica from food-producing 
animals (5–10). Soon following this, blaCMY-2 was found to be harbored by S. enterica and 
K. pneumoniae that were causing disease in humans (11, 12). As the genome sequencing 
era commenced, several fully sequenced plasmids were generated, enabling comparative 
plasmid genomics. It became increasingly evident that blaCMY-2 was often carried on 
IncA/C plasmids, and that these plasmids also encoded resistance to numerous other 
antimicrobials (13–16). Studies by the U.S. Food and Drug Administration examining 
clinical isolates from 1940-2000 showed that IncA/C plasmids and their associated 
multidrug resistance phenotypes emerged in S. enterica serovar Newport isolates after 
1980. Taken together, the literature suggests that IncA/C plasmids conferring resistance 
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to antimicrobials emerged in aquatic bacteria and subsequently moved into enteric 
bacteria carried by terrestrial animals. The problem with this conclusion is that strains 
carrying IncA/C plasmids have historically been isolated by screening for resistance 
phenotypes first, followed by identification of the IncA/C replicon. Still, Gram-negative 
pathogens harboring IncA/C plasmids are now common, and these plasmids are notorious 
for carrying genes that confer resistance to multiple classes of antimicrobials. 
  
 How IncA/C plasmids were able to rapidly disseminate throughout genera of 
enteric bacteria is still an open question. Certainly, their ability to be carried by many 
different species of Gammaproteobacteria is probably a factor (17). There are some 
IncA/C variants that have possibly lost the ability to transfer by conjugation (18), 
however, the origin of transfer has been described and can facilitate mobilization by trans 
acting conjugative machinery (19). There are documented cases of the short-term ability 
of these plasmids to disseminate in hospital settings. For example, a 2-year outbreak 
study in a Tunisian hospital involving multidrug-resistant Providencia stuartii identified 
IncA/C plasmid variants that had circulated among three bacterial clones (20).  
  
 IncA/C plasmids are unique among other plasmid types in enteric bacteria. They 
seem to be a chimera of the remnant of an integrative conjugative element similar to that 
of SXT/R391 (21) and an iteron-containing theta replicon. Comparative sequence 
analyses of IncA/C plasmids have revealed that their backbone is punctuated by several 
hotspots for integration of a variety of mobile genetic elements such as IS26, ICEcp1, and 
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class 1 integrons (15, 16, 22–25). These mobile elements carry with them a variety of 
genes that confer the resistance to multiple classes of antimicrobials. Given these 
hotspots, the potential for gene shuffling with this plasmid type is high, and this has 
certainly been observed in comparative genomics studies (16, 23, 26, 27). IncA/C 
plasmids now have been sequenced from isolates of E. coli, S. enterica, Vibrio cholerae, 
Yersinia pestis, Photobacterium damselae subsp. piscicida, Yersinia ruckeri, and 
Klebsiella pneumoniae. Multiple lineages of IncA/C plasmids now have subsequently 
been identified, however, recent papers have suggested that there are simply two major 
lineages, one containing the original pRA plasmid from aquatic pathogens, and a second 
containing all contemporary plasmids (26). The low variability in the backbone 
sequences, combined with the multitude of combinations of mobile elements that have 
been described in the hotspot regions, leads one to believe that the all of the different 
variants of IncA/C plasmids have rapidly evolved from a common ancestor. For example, 
IncA/C plasmids acquiring the blaNDM-1 gene encoding the New Delhi metallo-β-
lactamase have successfully disseminated among clinical K. pneumoniae and E. coli 
originating in India (28, 29). Therefore, it seems likely that both horizontal gene transfer 
and clonal dissemination must play an important role in the success of IncA/C plasmids, 
although the abundance of these plasmids in the environment and their full range of 
bacterial hosts is not yet appreciated. 
  
 Initial comparative analyses concluded that the backbones of IncA/C plasmids were 
upwards of 99% conserved on the nucleotide level, with major differences being only in 
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the resistance-associated insertion elements in their hotspot regions. This remains largely 
true amongst plasmids originating from enteric bacteria. With the growing number of 
fully sequenced IncA/C plasmids from other sources, both published and unpublished, 
that number is down to 72-94% (26, 30). The diversity of IncA/C plasmids is likely to be 
underappreciated. This is likely due to a primary focus on plasmids conferring resistance 
to multiple antimicrobials. If this is true, the high conservation among IncA/C plasmids 
of enteric bacteria indicates a common ancestral plasmid origin and subsequent rapid 
dissemination. 
  
 IncA/C plasmids possess a number of putative transcriptional regulators with 
sequence similarity to proteins of the H-NS, HU-β, Xre, LysR, GntR and LuxR families 
(16). The presence of such proteins on large, low copy plasmids is not unexpected. Other 
large plasmids, such as IncP, IncH, and IncX, also encode H-NS-like proteins and other 
transcriptional regulators (31–33). Some of these proteins have been shown to exhibit 
silencing effects on the bacterial chromosome, suggesting that this might be a key activity 
in the successful dissemination of these plasmids to a broad range of bacterial hosts. 
However, the high number of putative regulatory genes that IncA/C plasmids possess 
suggests that strict regulation of both the plasmid and naïve host chromosome is critical 
for their broad-host dissemination. Interestingly, the closest database matches to these 
protein sequences are from non-enteric bacteria such as Vibrio spp. and Aeromonas spp., 
indicating that a possible origin of this plasmid type could have been soil or water 
bacteria (16). One could speculate that these plasmids are well suited to persist in certain 
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subsets of reservoir bacteria, in which they provide a lower imposed fitness cost to their 
bacterial host and are better able to persist in a microbial community. It has been 
demonstrated that IncA/C plasmids in hosts such as E. coli and Salmonella might require 
selective pressure for their long-term persistence (34). However, if other reservoir 
bacteria are better suited to carry IncA/C plasmids regardless of antimicrobial selection, 
they may persist for long periods of time. This would afford IncA/C plasmids the 
opportunity to reside in a microbial community in the absence of benefit to an enteric 
host, to persist, and to subsequently emerge in pathogens. 
  
 Many questions remain related to IncA/C plasmid biology. Until very recently, 
none of these aspects have been functionally characterized. Early studies identified the 
minimum replicon of IncA/C plasmids, showing that the repA gene was functional and 
was sufficient and necessary for replication (24, 25). Only two other studies, both 
published during the preparation of this thesis, have examined IncA/C plasmids in 
molecular detail. One detailed the origin of transfer (19) and the other focused on the 
regulation of transfer (35). This thesis describes the results of three studies that aim to 
further characterize IncA/C plasmids in detail. Chapters 2 and 3 use total RNA 
sequencing (RNA-Seq) to map and characterize global gene expression in cells carrying 
an IncA/C plasmid. Specifically, Chapter 2 looks at the effect of antimicrobials on 
plasmid gene transcription. Chapter 3 attempts to better understand the influence that host 
chromosomal background has on plasmid gene transcription, as well as what effect 
plasmid carriage has on chromosomal gene transcription. In Chapter 4 we characterize 
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the function of a set of predicted transcriptional regulators encoded on IncA/C plasmids 
and their role in the regulation of conjugation. 
  
 The results presented in this thesis provide an outline for studying IncA/C plasmid 
regulatory networks in molecular detail. This thesis merely scratches the surface of such 
networks, as there are many more predicted DNA binding proteins encoded on IncA/C 
plasmids whose functions have yet to be explored. 
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Chapter 2 
Transcriptome mapping of pAR060302, a blaCMY-2-
positive broad host range IncA/C plasmid3 
 
 
 
 
 
 
 
 
 
 
 
                                                 
3 This chapter has been previously published in: 
Kevin S. Lang, J. L. Danzeisen, W. Xu, and T. J. Johnson.Transcriptome mapping of pAR060302, a 
blaCMY-2 positive IncA/C plasmid. Applied and Environmental Microbiology. 2012 78:3379-3386. 
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Summary 
The multidrug resistance-encoding plasmids belonging to the IncA/C incompatibility 
group have recently emerged among Escherichia coli and Salmonella enterica in the 
United States. These plasmids have a unique genetic structure, a broad host range, and 
propensity to acquire large numbers of antimicrobial resistance genes via their accessory 
regions. Using E. coli strain DH5α harboring the prototype IncA/C plasmid pAR060302, 
we sought to define the baseline transcriptome of IncA/C plasmids under laboratory 
growth and in the face of selective pressure. The effects of ampicillin, florfenicol or 
streptomycin exposure were compared to cells left untreated at logarithmic phase using 
Illumina sequencing (RNA-Seq). Under growth in Luria-Bertani broth lacking 
antibiotics, much of the backbone of pAR060302 was transcriptionally inactive, 
including its putative transfer regions. A few plasmid backbone genes of interest were 
highly transcribed, including genes of a putative toxin-antitoxin system and an H-NS-like 
transcriptional regulator. In contrast, numerous genes within the accessory regions of 
pAR060302 were highly transcribed, including the resistance genes floR, blaCMY-2, aadA, 
and aacA. Antibiotic treatment with ampicillin or streptomycin resulted in no genes being 
differentially expressed compared to controls lacking antibiotics, suggesting that many of 
the resistance-associated genes are not differentially expressed due to exposure to these 
antibiotics. In contrast, florfenicol treatment resulted in the up-regulation of floR and 
numerous chromosomally encoded genes. Overall, the transcriptome mapping of 
pAR060302 suggests that it mitigates the fitness costs of carrying resistance-associated 
genes through global regulation with its transcriptional regulators. 
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Introduction 
Antimicrobial resistance is a growing public health concern, as the emergence and 
rapid dissemination of multidrug resistance (MDR) phenotypes among human and animal 
pathogens presents limited options for disease treatment. The spread of MDR-encoding 
genetic determinants has been attributed to indiscriminate use of antimicrobial 
compounds in animal agriculture and human health, although it is still unclear if there are 
factors aside from antimicrobial selection pressure that drive the persistence of these 
resistance genes (36–38). Often these genes reside on mobile genetic elements that have 
been circulating among bacteria for far longer than antibiotics have been used by 
humans(39, 40). Horizontal gene transfer of these elements provides a mechanism for 
rapid spread of MDR among bacteria, thus the factors driving the persistence and 
dissemination of these mobile elements play a large role in the circulation of resistance 
genes in the absence of selection pressure. 
 
Horizontal gene transfer plays a significant role in the introduction of new genes 
into microbial populations (41). Conjugative plasmids, integrons and transposons all 
contribute as vehicles for this process. Plasmids are extrachromosomal genetic elements 
that orchestrate their own replication. In some cases they are able to move via 
conjugative transfer. The sizes of plasmids can vary widely (1.5 kb to >600kb) and are 
generally considered modular in nature. Core components of plasmids are required for 
their replication, stability and, in some cases, their transfer. The acquisition of accessory 
elements by plasmids can result in a wide variety of phenotypes to their host recipient, 
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such as antimicrobial and heavy metal resistance, metabolism of organic compounds, and 
virulence (42–45). Plasmids belonging to the A/C incompatibility plasmid group 
(IncA/C) are a mosaic of a highly conserved core backbone with variable accessory 
elements. These are large (ca 80 – 160 kb) broad-host-range plasmids and have been 
isolated from diverse groups of Proteobacteria found in the environment, food animals, 
food products and human pathogens (43, 46–48). IncA/C plasmids are of particular 
concern because they carry genes that encode resistance to many different antimicrobial 
compounds, including blaCMY-2, which encodes an AmpC-like β-lactamase that confers 
resistance to 3rd-generation cephalosporins (49). The physical linkage of this gene to 
other resistance genes encoded on IncA/C plasmids presumably allows it to persist in the 
absence of cephalosporin use. The ability of IncA/C plasmids to spread blaCMY-2 and co-
transferring resistance genes to a diverse range of bacteria poses a threat to both human 
and animal health.  
 
Numerous IncA/C plasmids have been fully sequenced (15, 16, 23), though little 
is known about their basic biology. One such plasmid, pAR060302, is a ~166 kb MDR-
encoding plasmid that was isolated from a dairy cow Escherichia coli strain AR060302 
in 2003 (16). The backbone of this plasmid appears to contain genes required for 
replication, maintenance, and conjugative transfer. Additionally, three distinct accessory 
elements are encoded on this plasmid: an ISCR2-containing element that carries the floR, 
tetA, strBA, and sul2 genes; an ISEcp1-containing element that carries the blaCMY-2 gene; 
and a Tn21-like, class I integron-containing element that carries several different gene 
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cassettes, including aadA, which confers aminoglycoside resistance. Although many of 
the phenotypes have been described for this plasmid, the extent to which these genes are 
transcribed and regulated remains unknown. Similar to many other plasmids, the 
transcriptional pattern of the plasmid backbone genes and accessory elements are likely 
regulated by a combination of plasmid encoded transcriptional regulators and host factors 
(31). Environmental conditions could also play a role in this regulation. The magnitude of 
the transcription of these genes can impact phenotypes encoded on these plasmids (50). 
Due to the presence of multiple antimicrobial resistance genes on IncA/C plasmids, their 
propensity to acquire new genes, their broad host range, and their rapid dissemination, 
there is an immediate need to understand the underlying mechanisms of this plasmid’s 
regulation. 
 
The present study aimed to characterize the transcriptome of pAR060302, a 
prototypical blaCMY-2 positive IncA/C plasmid, under laboratory conditions using 
Illumina based RNA sequencing methods (RNA-Seq). We hypothesized that the level of 
transcription would vary between plasmid backbone genes and those encoded on 
accessory elements and that the transcriptional landscape of pAR060302 would differ 
under antimicrobial selection pressure. Therefore, we mapped the transcriptome of 
pAR060302 to provide initial insights on the regulation of gene expression of this 
plasmid. 
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Results 
Transcription of the plasmid core regions. Much of the putative backbone of 
pAR060302 was transcriptionally inactive under the conditions examined (Figure 1). 
Only about 18 percent of the coding sequences located in core regions were transcribed. 
The repA replication initiation gene was expressed at a low level (RPKM of ~3700-
4700). This gene was used for subsequent comparisons because it is involved with 
plasmid replication and was assumed to be expressed consistently during exponential 
growth due to continuous cell division. Just one other locus, containing ORF_051-053, 
was expressed on the backbone of the plasmid in a similar pattern to repA (Table 1). 
BLASTp analysis of ORF_051-053 identified two of these putative proteins as having 
functions pertaining to stability and maintenance. Two additional regions were 
transcribed at high levels, but had not previously been annotated (Figure 2). These two 
regions have short predicted ORFs (< 65 amino acids) however it is unclear which small 
peptides, if any, are expressed by these transcripts. Nucleotide BLAST (megablast) 
analysis of the regions showed similarity only to other IncA/C plasmids, which indicates 
that it is unlikely that these reads were mapped incorrectly. These regions did not have 
similarity to the host E. coli genomic sequences and therefore did not originate from 
chromosomal transcripts.  
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Figure 1: Heat map displaying transcriptome map of pAR060302.  Blue indicates no or low expression (0-75 reads aligned per 
nucleotide position), green indicates moderate expression (250-500) reads aligned per nucleotide position), and red indicates high 
expression (>2500 reads aligned per nucleotide position).  In the pAR060302 (pAR) map, the shaded regions indicate the plasmid 
backbone as follows: red (IncA/C replicon and hypothetical genes), blue (Tra1 region), and green (hypothetical genes and Tra2 
region).  Open boxes depict the accessory regions as follows: pink (flo-tet-sul containing region; enlarged in figure 4), green (blaCMY-2 
containing region; enlarged in figure 5), and blue (Tn21-like region which contains a class 1 integron; enlarged in figure 6). 
aAntibiotics are abbreviated as follows: ampicillin (Amp), florfenicol (Ffl), streptomycin (Str). 
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Table 1: RPKM values calculated for transcribed genes of interest.  RPKM is calculated as reads aligned per kilobase of gene per 
millions of total reads. 
  
Genes or ORFs Function or predicted function 
RPKM values 
  Control Ffla Ampa Stra 
  repA replication initiation 4376 3780 4772 4753 
Putative maintainence and 
stability genes 
pAR060302_0051 putative ParA partition protein 6942 11,306 7534 7066 
pAR060302_0052 putative ParB partition protein 14,265 20,154 13,480 14,939 
                  
  pAR060302_0023 putative IHF transcriptional regulator 5130 2097 5583 5243 
Putative DNA binding 
genes 
pAR060302_0025 putative antitoxin component protein 206,070 361,900 201,615 203,271 
pAR060302_0026 putative toxin component protein 86,543 148,982 85,362 81,898 
pAR060302_0027 putative DNA binding protein  3176 3074 3431 3769 
  pAR060302_0188 putative HNS-like protein  23,351 14,876 26,414 27,179 
                  
  floR phenicol resistance 8543 71,346* 8463 8845 
Resistance genes 
tetA tetracycline resistance 991 1544 958 993 
blaCMY-2 extended spectrum beta-lactamase 34,314 35,415 32,488 32,308 
aadA aminoglycoside resistance 323,889 217,434 334,860 330,472 
  aacA aminoglycoside resistance 64,841 61,992 56,338 61,287 
                  
Genes within the putative 
transfer loci 
pAR060302_0075 hypothetical protein 8277 3343 8070 8170 
pAR060302_0097 hypothetical protein 13,364 6383 14,597 13,921 
pAR060302_0183 hypothetical protein 3452 5266 3985 4104 
                  
 aAntibiotics are abbreviated as follows: ampicillin (Amp), florfenicol (Ffl), streptomycin (Str). 
*Indicates a > 3 fold change in expression that is statistically significant (q-value < 0.05)Its location is similar to the locations of the 
regulators of the transfer regions of SXT-like integrative conjugative elements (ICEs) that share significant homology with IncA/C 
plasmids (41). However, no work has been done previously to characterize this gene.   
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Figure 2: Transcription of regions not previously annotated. (a) Region between two IS26 
elements upstream of the ISCR2 elements. (b) Intergenic transcript downstream of the 
class I integron.  Antibiotic treatment conditions are labeled along the x-axis.  The x-axis 
has a scale of 0 – 2500 reads aligned per base.  Arrows indicate direction of transcription. 
aAntibiotics are abbreviated as follows: ampicillin (Amp), florfenicol (Ffl), streptomycin 
(Str). 
 
The majority of the genes located in the Tra1 and Tra2 regions of pAR060302 
were not transcribed under the conditions we assayed. Only three genes within these loci, 
ORFs 75, 97 and 183, were transcribed under the conditions examined here (Table 1). 
The expression levels of these genes were comparable to the level of repA and are all 
annotated as hypothetical proteins. The gene locus pAR060302_183 is annotated as a 
hypothetical protein. This ORF is conserved among IncA/C plasmids, but shares no 
similarity to proteins with known functions.  
  17 
A few genes on the backbone of pAR060302 were expressed at high levels. One 
set of genes transcribed at a level 47- and 20-fold higher than repA was pAR060302_25 
and pAR060302_26, respectively (Table 1, Figure 3a), which display BLAST similarity 
genes of a toxin-antitoxin system, although this system has not been experimentally 
characterized as having toxin-antitoxin function. pAR060302_25 is a putative XRE-like 
transcriptional regulator and the putative antitoxin component, while pAR060302_26 is a 
putative toxin component of the system. These predicted proteins share amino acid 
similarity (70%) to a chromosomal locus found in Salmonella enterica serovar Paratyphi 
B strain SPB7. A third gene, pAR060302_188, was transcribed at a level 5-fold higher 
than repA (Table 1, Figure 3b) and is annotated as a putative H-NS-like DNA-binding 
protein. Analysis of the predicted amino acid sequence of pAR060302_0188 showed 
52% sequence similarity to its closest match and did not show any significant similarity 
to other H-NS proteins encoded on other gram-negative plasmids; however it is 
conserved among all sequenced IncA/C plasmids (10). 
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Figure 3: Transcriptome maps of plasmid backbone genes of interest. (a) 
pAR060302_0025 and pAR060302_0026 are transcribed at extremely high levels.  The 
x-axis has a scale of 0 – 30,000 reads aligned per nucleotide position.  Arrows indicate 
direction of transcription.  (b) pAR060302_0188 is transcribed as a single gene transcript.  
The x-axis has a scale of 0 – 2500 reads aligned per nucleotide position.  Arrows indicate 
direction of transcription.   
aAntibiotics are abbreviated as follows: ampicillin (Amp), florfenicol (Ffl), streptomycin 
(Str). 
Transcription pattern of the pAR060302 accessory regions. There are at least 
three hotspots for insertion of mobile genetic elements on IncA/C plasmids (6, 10, 12). In 
pAR060302, the first hotspot carries an ISCR2-containing mobile genetic element that 
contains the floR, tetRA, strBA, and sul2 resistance gene cluster; as well as several 
putative genes with predicted regulator capabilities. This inserted module is highly 
conserved among blaCMY-2 positive IncA/C plasmids (6). The floR gene was transcribed 
on a transcriptional unit that includes three ORFs and this transcript was apparently 
promoted by a dual promoter system (Figure 4). A transcriptional start site (TSS) was 
located upstream of ORF_0040, a conserved hypothetical protein, and an inducible 
promoter was located just upstream of the floR ORF. The transcription of floR was 
increased ~8 fold (q-value < 0.05) from this promoter site after exposure to florfenicol for 
30 min. Immediately downstream of floR, pAR060302_0042 was also up-regulated. This 
gene likely resides on the same transcript give the pattern of aligned reads that was 
observed (Figure 4). pAR060302_0042 is annotated as a hypothetical protein. Blastp 
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analysis of the predicted amino acid sequence of this ORF showed a predicted helix-turn-
helix domain and shares homology with the LysR family of transcriptional regulators. No 
changes in transcription of this region were observed in the presence of ampicillin or 
streptomycin. Located downstream of the floR locus on the opposite strand is the tetRA 
gene cluster, one of the most abundant genetic factors for antimicrobial resistance in 
Gram-negative bacteria. The transcriptional regulation of tetRA has been previously 
characterized (51) and similar phenomena were observed here. That is, only the repressor 
gene tetR was transcribed while the tetA gene was under repression. This gene cluster has 
been shown previously to be up-regulated in response to tetracycline exposure (51) but 
was unaffected by the antimicrobial compounds we tested here. The strBA and sul2 
genes, encoding streptomycin and sulfonamide resistance respectively, are located on the 
ISCR2 element upstream of tetRA and were transcribed together on the same transcript 
originating with a TSS located just upstream of sul2. Florfenicol, ampicillin or 
streptomycin treatment had no effect on the abundance of this transcript. 
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Figure 4: Transcriptome map of the sul2 containing region of pAR060302. Antibiotic 
treatment conditions are labeled along the x-axis.  The y-axis has a scale of 0 – 2500 
reads aligned per base.  Arrows indicate direction of transcription.   
aAntibiotics are abbreviated as follows: ampicillin (Amp), florfenicol (Ffl), streptomycin 
(Str). 
*Indicates a statistically significant greater or less than log2(fold change) in expression 
(q-value < 0.05). 
 
The second hotspot in pAR060302 contains the blaCMY-2 gene, which is part of an 
ISEcp1-containing mobile genetic element also containing blc1 and sugE1. It is inserted 
amongst plasmid backbone genes predicted to be involved with conjugative transfer 
(Figure 5). There are 22 ORFs in the previously defined Tra1 gene cluster (16). In all 
blaCMY-2 positive IncA/C plasmids that have been sequenced thus far, the ISEcp1 mobile 
element containing blaCMY-2 is inserted in this region (15). In pAR060302 this insertion is 
located downstream of traA, but this site of insertion is not conserved amongst all IncA/C 
plasmids. The ISEcp1-containing element of pAR060302 appeared to carry its own 
strong promoter just downstream of ISEcp1 conferring a high level of transcription of 
blaCMY-2, which was not changed in the presence of ampicillin, florfenicol or 
streptomycin. Downstream of blaCMY-2, both blc1 and sugE1 were minimally transcribed 
compared to the level of blaCMY-2 transcription, indicating that there may be a 
transcription stop site between blaCMY-2 and these two genes. 
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Figure 5: Transcriptome map of the blaCMY-2 containing Tra1 region of pAR060302. 
Antibiotic treatment conditions are labeled along the x-axis.  The x-axis has a scale of 0 – 
2500 reads aligned per base.  Arrows indicate direction of transcription. 
aAntibiotics are abbreviated as follows: ampicillin (Amp), florfenicol (Ffl), streptomycin 
(Str) 
 
Nearly all sequenced blaCMY-2 positive IncA/C plasmids carry a Tn21-like class I 
integron region in their third accessory hotspot (6). The class I integron of pAR060302 
contains aminoglycoside resistance genes, aadA and aacC; heat-shock chaperones 
groSEL; the qacEΔl and sul1 genes; and the merDBAPTR mercury resistance operon. Our 
data suggest that a transcript started from an apparently strong promoter upstream of 
aadA and continued until just down downstream of groEL where transcription seemingly 
halted. aadA was transcribed at a level 74-fold higher compared to repA, while aacC and 
groSEL were transcribed at decreasing levels (Figure 6). This position-dependent 
transcription of integrons has been previously observed (52). The transcription of this 
region was not affected by treatment with ampicillin, florfenicol, or streptomycin. The 
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merDBAPTR gene cassette, previously shown to be activated in the presence of mercuric 
compounds (53), was unaffected by treatment with the three antibiotics used here. 
  
Figure 6: Transcriptome map of the class I integron containing region of pAR060302. 
Antibiotic treatment conditions are labeled along the x-axis.  The x-axis has a scale of 0 – 
2500 reads aligned per base.  Arrows indicate direction of transcription. 
aAntibiotics are abbreviated as follows: ampicillin (Amp), florfenicol (Ffl), streptomycin 
(Str). 
  
 E. coli chromosomal transcriptional response to exposure to antimicrobials. 
Reads obtained from each treatment were also mapped to the chromosome of the E. coli 
DH5α host. Both the ampicillin and streptomycin treatments yielded no differentially 
transcribed genes on the chromosome that were statistically significant. However, the 
florfenicol treatment resulted in 286 chromosomally encoded genes which were 
transcribed statistically significantly different levels compared to the control cells. Most 
of these genes (~250) were down regulated, whilst the remaining genes were up 
regulated. Among the genes that had increased expression were rbfA, deaD, cspA and 
cspG, which are annotated as being induced upon cold shock. Two transmembrane 
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tranporters, proP and mdtK, were also up-regulated. Several genes annotated as part of 
the σs-directed stress response were down-regulated. These include the dps gene, which 
encodes a histone-like protein that forms clusters with DNA, the acid response genes 
gadC and hdeAB, and the cfu gene, which is involved with alterations of the cell 
membrane (54). 
 
Discussion 
IncA/C plasmids have been increasingly associated with the dissemination of 
antimicrobial resistance genes in populations of enteric bacteria from humans and 
animals. To gain insights on the biology of these plasmids we conducted RNA 
sequencing experiments, resulting in the first report of the transcriptional landscape of 
these large plasmids. IncA/C plasmids are distributed globally, yet remain highly similar 
aside from their accessory elements (15, 16, 23). Data generated in this study, therefore, 
may be applied broadly across the many sequenced IncA/C derivatives. Illumina based 
RNA-Seq provided a robust approach to mapping the transcriptional levels down to the 
single base pair. This provided an opportunity to amend the current annotation of 
pAR060302 and gain insights into the genetic determinants of plasmid maintenance and 
stability.  
 
When studying plasmid biology the host carrying any given plasmid is inherently 
important. Plasmids rely on their host cell for aspects of DNA replication and gene 
expression. In the present study E. coli strain DH5α was used as the host cell. This 
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common lab strain is well adapted to growth in lab media. It is probable that the extent to 
which DH5α is able to respond to external stimuli is severely muted compared to that of 
wild-type bacteria. In the present study, we observed that only florfenicol treatment 
altered chromosomal transcription, which was unexpected. No clear pattern emerged 
from the analysis of the differentially expressed chromosomal genes. This may be 
evidence that E. coli DH5α is ill-equipped to respond to environmental stresses. Another 
possibility could be that our strain most likely represents a naïve host-plasmid 
relationship and this interaction may be confounding the effects of antimicrobial 
exposure. Indeed, other hosts would likely have a larger impact on plasmid 
transcriptional profiles due to the overlap of their spectrum of regulatory networks. The 
ability of chromosomal regulatory networks to interact with plasmid encoded regulatory 
networks ultimately governs plasmid gene expression. Therefore, while the present study 
sought to define IncA/C transcription in the absence of complex interactions between the 
host chromosome and plasmid, it will be necessary in future work to study the effects of 
IncA/C transcription in additional bacterial hosts and growth conditions to fully 
appreciate the plasmid-host relationship.  
 
Two of the three accessory regions of pAR060302 were transcribed at high levels 
compared to the backbone of the plasmid, while the floR-tetRA-strAB-sul2 region was 
not. Evidence of transcription of these genes supports phenotypic observations of their 
ability to confer resistance against high concentrations of antimicrobial compounds. 
However, there could also be consequences associated with their expression at high 
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levels in the absence of antibiotic selection pressure. A recent study by Call et al. (34) 
showed that the blaCMY-2 region of pAR060302 is prone to stochastic excision and, in the 
absence of selection pressure, populations of E. coli harboring blaCMY-2 were out-
competed by blaCMY-2-lacking plasmids over many generations. Other studies have shown 
a significant cost of carrying other variants of AmpC-like beta-lactamase genes (55, 56). 
It was hypothesized that this cost is a result of unregulated expression and that this cost of 
carriage results in reduced dissemination. It is also possible that IncA/C plasmids 
mitigate the fitness cost conferred by blaCMY-2, to some extent, to allow its persistence and 
spread.  
 
Call et al. also showed that the flo-tet region was prone to apparent excision over 
time, but required significantly more generations to be lost from pAR060302-containing 
bacterial populations. We show here that floR gene transcription is transcribed at 
relatively low levels compared to the other resistance genes of pAR060302, but is 
seemingly induced by the presence of florfenicol. Florfenicol has been previously shown 
to increase expression of other genes and this was found to be a result of increased half-
life of mRNA due to the presence of florfenicol (57). Still, the transcript containing floR 
was the only plasmid encoded mRNA that was significantly up-regulated in response to 
antibiotic treatment. Other mechanisms resulting in the induction of expression of 
resistance genes by exposure to florfenicol have been described before (58). The putative 
transcriptional regulator immediately downstream of floR may represent a control 
mechanism for the regulated transcription of floR. No previous studies have addressed 
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this. However, since florfenicol was the only treatment that resulted in altered 
chromosomal expression this may instead be a result of chromosome-plasmid “cross-
talk”. Given that many genes on the chromosome were differentially transcribed, why 
only a specific mRNA on the plasmid was affected remains in question. It is unclear at 
this time what the molecular basis for the increased floR transcripts we observed might 
be. Others have shown that the tetRA region is induced by tetracycline (51), which is 
likely the case in pAR060302 given our results. While strAB was transcribed and was not 
induced by the addition of streptomycin to the media in our experiments, it was 
transcribed at a much lower level than that of blaCMY-2, aadA, or aacC. Thus, the 
increased stability of the flo-tet region observed by others could be correlated to a lower 
fitness cost for the carriage due to its apparent regulation. This is in contrast to the 
apparently uncontrolled transcription of blaCMY-2 and genes within the Tn21-like region, 
which were highly transcribed under all of our study conditions. The stability of the 
Tn21-like region over long periods of time in the absence of antimicrobial selection 
pressure has yet to be measured, although we expect that portions of this region would 
also be deleted over time due to the relative cost of high transcription. This could, in part, 
explain why some sequenced IncA/C plasmids, such as pAM04528 (16), only possess the 
mer operon and lack other Tn21-associated genes. Further analysis is required to verify 
the impact of gene expression on the evolution of IncA/C plasmids. 
 
Several genes have been identified here that might be key to this plasmid’s 
success, including several putative plasmid-encoded transcriptional regulators that were 
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transcribed at high levels compared to other backbone components. In other plasmid 
systems, similar genes have been shown to have a wide array of affects. For example, the 
IncP-7 plasmid group encodes an H-NS like protein Pmr, and recent studies have shown 
that Pmr alters the transcriptional landscape of the host chromosome (31). R27, an IncH 
plasmid isolated from Salmonella enterica servar Typhimurium, encodes Sfh, another H-
NS-like protein. Deletion of this gene resulted in a nearly 4-fold increase in the number 
of chromosomally encoded genes that were differentially expressed due to plasmid 
acquisition (32). These H-NS-like proteins have been termed “stealth-like” and have been 
hypothesized to silence the effects of plasmid acquisition on the host chromosome. A 
recent survey of sequenced plasmids found that similar genes reside on many known 
broad-host-range plasmids (59). All sequenced IncA/C variants encode a putative H-NS 
like protein that could represent a genetic factor enabling transfer and/or stability among 
diverse host backgrounds. H-NS orthologs might provide alleviation of the cost of 
plasmid carriage incurred by the host cell. However, the putative H-NS-like regulator of 
pAR060302 shares low amino acid similarity to its closest known match (16), so it is still 
necessary to elucidate the role this gene plays, if any, in the success of IncA/C plasmids 
in their diverse hosts.  
 
The putative toxin-antitoxin system of pAR060302 was also highly transcribed 
under the conditions studied. Such systems are well known for their involvement in post-
segregational killing in plasmid-free daughter cells (60). The transcription of this system 
in pAR060302 suggests that IncA/C plasmids ensure their stability in bacterial 
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populations by potentially killing plasmid-free progeny that may arise. However no 
previous work has been done to describe the function of these genes found in IncA/C 
plasmids. 
 
Within the putative conjugal transfer regions of pAR060302, only a few genes of 
unknown function were transcribed in our study. pAR060302 has been shown to be 
transferrable by our group and by others (15). The apparent conjugal transfer machinery 
of IncA/C plasmids is unlike that of any other known plasmids, but is highly syntenic to 
the transfer loci of SXT/R391 ICE elements (21). These ICEs have a highly regulated 
transfer mechanism, suggesting that the same is true for IncA/C plasmids. Yet, the key 
regulators of R391-like ICEs are missing from IncA/C plasmids, pointing to potentially 
novel mechanisms of regulation (61–63). Several scenarios could explain the regulation 
of the transfer region in IncA/C plasmids. One possibility is that the region may be 
simply unregulated, however, this is unlikely due the inability to observe transcription of 
the tra genes. Another possibility is that the transfer loci may be under host cell control 
as is the case for plasmids that undergo zygotic induction; this too seems unlikely for a 
plasmid which such a broad-host range since relying on host-specific factors would result 
in an evolutionary dead-end if the plasmid were to transfer to a host unfit for such 
regulation. A third possibility is that IncA/C plasmids may encode their own genes for 
regulation of the transfer loci. This seems to be the most likely scenario, since these 
plasmids harbor an array of putative regulators, some of which might regulate the 
expression of the transfer loci. Other plasmid systems rely on a signal from suitable 
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recipients to initiate plasmid transfer, and although this has not been described for 
plasmids in Gram-negative bacteria it remains to be tested for IncA/C plasmids (9). 
Given the role that IncA/C plasmids play in the dissemination of resistance genes among 
Enterobaceriaceae, the mechanisms by which they are transferred deserve further study. 
 
The data generated in this study afforded us the opportunity to examine the 
annotation of pAR060302 based on experimental evidence. The two short transcripts in 
areas not previously annotated could represent small peptides encoded on pAR060302. 
They could, alternatively, represent small non-coding RNAs (ncRNA). In E. coli, 
ncRNAs have previously been shown to be up to 300 bp in length (64, 65). Although the 
experimental design of our study was not specifically created to isolate ncRNAs, these 
transcripts are of appropriate length to be observed under our conditions. Further work is 
needed to identify the nature of these transcripts.   
 
A limitation to this work is that the data only represent a fraction of pAR060302 
transcription potential, since we only analyzed a single growth point of E. coli harboring 
pAR060302 in a single growth media. This provides insight to the minimum genetic 
components required for IncA/C plasmid maintenance under laboratory growth 
conditions. Our first hypothesis about transcriptional differences between plasmid 
accessory and backbone elements held true; it is remarkable that much of the backbone of 
pAR060302, including regions predicted to be involved in plasmid maintenance and 
stability, was transcriptionally inactive. This could imply the possibility of extensive 
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regulation and crosstalk between plasmid and host or self-regulation of the plasmid itself. 
We also hypothesized that the transcriptional profile of the plasmid would respond to 
antibiotic treatment, which was only true in the case of florfenicol treatment. It is 
probable that changes could occur if different classes of antibiotics were used, but it is 
interesting that many of the resistance genes were transcribed at high-levels in the 
absence of antibiotics.  
 
 Overall, RNA-Seq offers a robust approach to assess global scale transcription. In 
our data we can observe a polarity to the transcripts, which can offer clues to the location 
of the transcriptional start site. However, a different RNA-Seq experimental design than 
that used here would be needed to accurately map the start of nascent transcripts (66). 
Further studies such as these will move toward a global understanding of the expression 
of the genes on IncA/C plasmids and the implication of such expression on their overall 
biology. Host strain-dependent transcriptional profiles of other plasmids, such as IncP, 
have been previously reported (31, 32). Although we expect differences in transcription 
of pAR060302 in its wild-type host, E. coli strain DH5α was used in this study to obtain a 
baseline transcriptional profile of pAR060302. Our observations of pAR060302 
transcription indicates that it is likely highly regulated, allowing for its dissemination to a 
broad range of bacterial hosts and its stability within these hosts, despite the likely costs 
of encoding highly transcribed accessory regions encoding antibiotic resistance. Future 
efforts will use these data to better understand the impacts of host background and 
plasmid-encoded genes on its transcription and regulation. 
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Materials and Methods 
Bacterial strains and growth conditions.  E. coli strain DH5α harboring 
pAR060302 was grown in 10 mL DifcoTM Luria-Bertani (LB) broth aliquots at 37º C 
with shaking until an OD600 of 0.5.  A total of 8 cultures were independently grown 
representing two biological replicates per condition tested.  Six of the cultures were 
amended, 2 cultures per antibiotic, with ampicillin (50 µg/mL final concentration), 
florfenicol (30 µg/mL final concentration), or streptomycin (50 µg/mL final 
concentration) and allowed to incubate at 37º C with shaking for an additional 30 min.  
Two cultures were not amended with any antibiotic.  Cells were pelleted and RNA was 
purified using a commercially available RNA extraction kit (Qiagen).  RNA preparations 
were then subjected to a DNase treatment to eliminate DNA contamination from the 
sample (Qiagen).  A treatment was also included to deplete ribosomal RNA using a 
commercially available kit (MicrobExpress, Ambion).  The two biological replicates for 
each growth condition were pooled for sequencing. 
 
Ilumina sequencing for transcriptome mapping. cDNA libraries were generated 
with an insert size of 100 bp and sequenced with 76-base cycles of single-end reads using 
a Genome Analyzer II (Illumina) platform according to manufacturer’s protocols at the 
Biomedical Genomics Center (University of Minnesota, Minneapolis, Minnesota, USA). 
Approximately 160,000 plasmid-mapped reads each were obtained for the ampicillin and 
streptomycin treated samples, and 260,000 plasmid-mapped reads each for the control 
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and florfenicol treatment samples. Genome-mapped read counts were as follows: control, 
~6.4 million reads, florfenicol treatment, ~5.7 million reads, ampicillin treatment, ~1.7 
million reads, and streptomycin treatment, ~5.2 million reads.  We only used those reads 
uniquely mapped on plasmid or chromosomal DNA for global normalization and further 
analysis. 
  
 RNAseq data analysis. cDNA reads were trimmed so that the quality at each base 
position was above 30 (~15-20 bp) and then mapped either to the E. coli K-12 MG1655 
published genome sequence (Genbank accession no. NC_000913) or to the pAR060302 
published sequence (Genbank accession no. NC_092692) using BOWTIE (67). The E. 
coli strain DH5α has an incomplete annotation and for this reason the E. coli K-12 
annotation was used, representing an estimation of differentially expressed genes due to 
exposure of antimicrobials. For each condition, graphs representing the number of 
mapped reads per nucleotide were generated and visualized using the Integrated Genome 
Viewer (IGV) (68). Images were created using XplasMap 
(http://www.iayork.com/XPlasMap/) and IGV. The reads mapped per kilobase of gene 
per million (RPKM) reads was calculated using either the E. coli chromosome or the 
pAR060302 annotation and was used for global normalization (69). The per kilobase 
cDNA length normalized the effect of different length of cDNAs such that the sequence 
reads have a equal chance to map on the long cDNA regions and the short cDNA regions. 
After RPKM normalization, each sample is comparable to each other. An R package, 
DEGseq (70), was used to identify differentially expressed genes between the control and 
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each antibiotic treatment condition. A cutoff of q-value < 0.05 and a fold change of > 3 
were used to measure statistical significance (70). 
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Chapter 3 
Transcriptome modulations due to IncA/C plasmid 
acquisition4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
4 This chapter is currently in review at the journal Plasmid 
Kevin S. Lang and Timothy J. Johnson. Transcriptome modulations due to IncA/C plasmid acquisition.  
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Summary 
Plasmids play an important role in driving the genetic diversity of bacteria. Horizontal 
gene transfer via plasmids is crucial for the dissemination of antimicrobial resistance 
genes. Many factors contribute to the persistence of plasmids within bacterial 
populations, and it has been suggested that epistatic interactions between the host 
chromosome and plasmid contribute to the fitness of a particular plasmid-host 
combination. However, such interactions have been shown to differ between bacterial 
hosts. In this study, RNA-Seq was performed in six different strains to characterize the 
influence of host background on the IncA/C plasmid transcriptome. In five of these 
strains, chromosomal transcriptomes were compared in the presence and absence of 
IncA/C plasmid pAR060302. Host-specific effects on plasmid gene expression were 
identified, and acquisition of pAR060302 resulted in changes in the expression of 
chromosomal genes involved in metabolism and energy production. These results suggest 
that IncA/C plasmid fitness could, in part, be dependent on host chromosome content, as 
well as environmental factors. 
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Introduction 
Antimicrobial resistance among Gram-negative bacterial pathogens is a public 
health crisis (71). The relative lack of drug discovery and the rapid emergence of 
multidrug-resistant (MDR) bacterial pathogens is a truly alarming combination. 
Horizontal gene transfer (HGT) is a major contributor to the spread of genes conferring 
multidrug-resistance. Understanding the factors driving the persistence of the elements 
facilitating HGT is crucial for the ability to better understand how to curtail the spread of 
multidrug resistance. 
 
Incompatibility group A/C (IncA/C) plasmids are a group of large (~100 ~ 200 
kb), broad-host-range plasmids that often carry genes conferring resistance to multiple 
classes of antimicrobials  (13, 15, 72, 73). They are commonly isolated from Gram-
negative Proteobacteria associated with aquatic and terrestrial animals, food products and 
human infections (24, 43, 48, 74, 75). Because IncA/C plasmids commonly confer 
multidrug resistance, it is easy to understand how this plasmid type persists in 
environments under selective pressures such as antibiotic therapy. It has been proposed 
that this plasmid type may even require antimicrobial selection pressure to persist in 
microbial populations (34), however these experiments focused on only one host strain. 
The interactions between plasmids and host chromosome have been reported in other 
plasmid types (76–80). These studies demonstrated that chromosomal background is a 
significant factor in the maintenance of plasmids. Crosstalk between the broad host-range 
IncA/C plasmid type and its host chromosome has yet to be explored. 
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 The present study attempts to better understand the IncA/C plasmid-host 
relationship through the use of total RNA sequencing (RNA-Seq). To determine if there 
were species-specific changes to the transcriptome of broad-host range plasmid 
pAR060302, or if there were common changes to the chromosomal transcriptional 
program during plasmid carriage, we examined the transcriptome of several different 
strains, spanning 3 genera of Gammaproteobacteria carrying pAR060302. We compared 
the transcriptome of pAR060302 in each host to that of the strain it was originally 
isolated in, AR060302. Finally, we compared the transcriptomes of the chromosomes of 
five strains with and without plasmid pAR060302. 
 
Results 
Analysis of the transcriptome of pAR060302 carried by different bacterial hosts. 
To understand how chromosomal background influences the pAR060302 transcriptome, 
a total of six strains carrying the plasmid were subjected to RNA-Seq. The sequencing 
reads were mapped to the pAR060302 reference sequence. Figure 7 shows the 
transcriptome map of plasmid pAR060302 while being carried by different bacterial 
hosts. Similar to what we have previously reported in E. coli strain DH5α (81), the genes 
most highly transcribed amongst all host species were resistance genes blaCMY-2, floR, 
strA, strB, aadA2/aadA1 and aac(3)-VIa, as well as the putative toxin-antitoxin module 
(locus tags pAR060302_0025 and 0026).  
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Figure 7. Transcriptome map of pAR060302 carried by different hosts. The rings from 
outside-in: 1) plasmid base pair coordinates; 2) gene map of pAR060302; 3-8) 
transcriptome maps of pAR060302 carried by S. oneidensis strain MR-1, S. enterica 
serovar Enteritidis strain MH16125, S. enterica serovar Heidelberg strain SL486, S. 
enterica serovar Newport strain SL317, E. coli strain DH10B, and E. coli strain 
AR060302. Genes on the map are colored by function: gray, hypothetical protein; red, 
antibiotic resistance; yellow, horizontal gene transfer; green, transcriptional regulation; 
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light purple, recombination; purple, DNA binding; blue, conjugal transfer; light blue, 
transglycosylase; orange, replication. Line plots represent average reads aligned to 250 
bp windows along pAR060302, normalized for sequencing library size and log-
transformed. Each line on the transcriptome maps represents 0.5 log. 
 
Table 2 displays differentially expressed genes on plasmid pAR060302 when comparing 
their transcription in the wild-type strain it was originally isolated in (AR060302) versus 
their expression when carried by a new host. Interestingly only 2 genes, qacEΔ1 and sul1, 
were differentially expressed across all host bacteria. Both genes were significantly 
down-regulated in all strains compared to their expression in AR060302. Given their 
organization on pAR060302, these two genes are probably transcribed from the same 
promoter. The genome sequence of strain AR060302 is not known and it cannot be ruled 
out that these genes might be expressed from somewhere on the chromosome, as well as 
pAR060302. Interestingly, the expression of many of the copies of IS26 are significantly 
down-regulated in all strains except DH10B. However, given how similar each copy of 
IS26 is, this result may be an artifact of the read aligner not being able to assign the read 
to the true copy its cognate transcript was transcribed from. Still, the overall number of 
reads originating from IS26 transcripts are lower in abundance in these strains compared 
to AR060302. It is possible that strain AR060302 has copies of IS26 somewhere on its 
chromosome that may contribute to the total number of reads aligning to copies of IS26 
on the plasmid. In either scenario, IS26 may be an active player in gene transfer events in 
the original host AR060302. Conversely, in S. oneidensis, the putative transposase genes 
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of ISCR2, ISCR16, and ISEcp1 are all significantly up-regulated, suggesting that genetic 
rearrangements are possible in this strain via mechanisms apart from IS26. Also of note, 
an entire region of genes from locus tag pAR060302_0098-0133 is significantly up-
regulated in strain SL486. Many of these genes have unknown functions and are 
dissimilar to any coding sequences in Genbank with known functions. A few of the 
coding sequences in this region do have predicted functions, most notably a phage-like 
site specific recombination operon, ssb-bet-exo. 
Summary of chromosomal transcriptome changes due to carriage of 
pAR060302. IncA/C plasmids are large, broad host-range plasmids (16, 23, 26). To better 
understand how acquisition of such a plasmid would influence chromosomal gene 
expression we compared chromosomal transcriptomes in five strains with and without 
pAR060302. In order to characterize broad shifts in chromosomal gene expression, lists 
of differentially expressed genes were subjected to COG ontology analysis using DAVID 
(82, 83). Table 3 shows the top COG ontologies enriched in both the down- and up-
regulated genes for each chromosomal background. Across all hosts, carriage of 
pAR060302 resulted in changes in expression of COGs related to oxidation/reduction 
reactions, cellular metabolism and/or metal cofactor binding. This suggests that plasmid 
carriage alters the metabolic demands of cells, which has been reported as a general 
phenomenon of plasmid carrying bacteria (84). Aside from central metabolism, the 
carriage of pAR060302 appears to change the expression of genes involved in 
localization, motility and adhesion in Salmonella strains, which may indicate a conserved 
interaction in that genus.
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Table 2. Fold change and p-value of genes on pAR060302.  
  
SL317 SL486 MH16125 MR-1 DH10 
Locus Tag Product log2FC log2FC log2FC log2FC log2FC 
pAR060302_0005 hypothetical protein -2.76 0.80 0.26 2.57 1.70 
pAR060302_0025 hypothetical protein -0.56 -1.21 -0.18 -1.02 1.83 
pAR060302_0034 IS26 -1.87 -2.08 -2.25 -3.01 -0.70 
pAR060302_0035 IS26 -2.64 -2.68 -3.12 -3.02 -1.69 
pAR060302_0039 ISCR21 TnpA 0.85 0.63 1.09 2.65 1.31 
pAR060302_0040 hypothetical protein -0.55 -1.30 -0.50 -0.06 1.85 
pAR060302_0041 FloR 2.11 0.36 0.68 0.94 3.67 
pAR060302_0042 hypothetical protein 2.10 0.21 0.59 1.71 3.28 
pAR060302_0044 TetA(A) 1.30 0.04 0.14 2.27 1.49 
pAR060302_0045 TetR(A) -0.82 -1.98 -1.41 -0.53 0.40 
pAR060302_0069 TraI 0.59 1.05 0.06 -0.95 -2.29 
pAR060302_0072 hypothetical protein 1.00 1.31 0.57 -0.94 -2.57 
pAR060302_0075 hypothetical protein 0.31 0.40 -0.19 -2.08 0.20 
pAR060302_0076 hypothetical protein 1.49 2.59 1.68 -0.69 -2.74 
pAR060302_0078 TraE 0.98 1.68 0.99 -1.73 -2.56 
pAR060302_0079 TraK family protein 0.80 1.44 0.68 -0.72 -2.24 
pAR060302_0081 TraV 1.53 1.89 0.99 -0.47 -1.41 
pAR060302_0082 TraA 1.84 2.33 1.28 0.82 -0.79 
pAR060302_0083 ISEcp1 TnpA -0.38 -0.03 -0.68 3.03 -1.23 
pAR060302_0084 CMY-2 -0.93 -1.21 -1.29 1.60 -3.93 
pAR060302_0085 outer membrane lipoprotein Blc 0.05 -1.33 -0.96 3.21 -0.56 
pAR060302_0086 SugE1 0.20 -1.49 -0.85 3.65 -0.99 
pAR060302_0087 hypothetical protein -0.20 -0.40 -1.98 1.27 -9.56 
pAR060302_0089 hypothetical protein 0.21 0.94 0.22 -0.54 -2.28 
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pAR060302_0090 TraC 0.54 1.10 0.45 -0.89 -2.42 
pAR060302_0091 hypothetical protein 0.09 1.31 0.47 -0.90 -4.43 
pAR060302_0092 TrhF 0.31 0.89 0.39 -0.96 -2.60 
pAR060302_0093 TraW 0.88 1.20 0.66 -0.77 -2.69 
pAR060302_0098 hypothetical protein 0.37 1.77 0.31 -0.17 -0.80 
pAR060302_0099 hypothetical protein 1.62 2.43 1.76 -0.25 1.41 
pAR060302_0100 hypothetical protein 1.36 2.24 1.12 0.14 1.41 
pAR060302_0101 ATPase  family protein 1.71 2.51 1.65 0.18 0.86 
pAR060302_0102 hypothetical protein 1.64 2.45 1.60 0.02 1.03 
pAR060302_0103 Ssb 1.82 2.26 1.34 0.13 0.94 
pAR060302_0104 Bet 1.68 2.48 1.63 0.33 1.04 
pAR060302_0105 exo 1.60 2.24 1.36 0.17 1.04 
pAR060302_0106 hypothetical protein 1.66 2.31 1.59 0.18 0.70 
pAR060302_0107 hypothetical protein 1.65 2.22 1.47 0.24 0.51 
pAR060302_0109 hypothetical protein 1.81 2.78 1.81 0.49 -1.09 
pAR060302_0110 hypothetical protein 1.92 2.86 1.96 0.39 -0.42 
pAR060302_0111 hypothetical protein 1.87 2.65 1.70 0.50 -0.54 
pAR060302_0112 ferredoxin family member protein 1.89 2.77 1.84 1.08 0.37 
pAR060302_0113 hypothetical protein 1.82 2.60 1.64 0.70 -0.58 
pAR060302_0114 hypothetical protein 1.97 2.71 1.69 0.96 0.05 
pAR060302_0115 hypothetical protein 1.86 2.87 2.08 1.07 0.52 
pAR060302_0116 hypothetical protein 1.61 2.61 1.83 0.58 0.65 
pAR060302_0117 hypothetical protein 1.77 2.64 1.73 1.03 0.79 
pAR060302_0118 hypothetical protein 1.82 2.38 1.94 0.46 1.92 
pAR060302_0119 hypothetical protein 2.14 2.66 2.10 0.46 2.07 
pAR060302_0120 Dcm 1.97 2.72 1.95 0.61 1.81 
pAR060302_0121 hypothetical protein 1.25 2.50 1.92 0.69 1.11 
pAR060302_0122 hypothetical protein 1.85 2.53 1.60 0.82 1.20 
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pAR060302_0123 hypothetical protein 1.47 2.04 1.58 -0.22 0.18 
pAR060302_0124 
phosphoadenosine phosphosulfate 
reductase 
1.34 1.91 1.08 0.28 0.66 
pAR060302_0125 hypothetical protein 2.06 2.32 1.60 -0.21 -0.40 
pAR060302_0126 HD phosphohydrolase family protein 1.91 2.57 1.72 -0.12 0.44 
pAR060302_0127 hypothetical protein 1.55 2.21 1.31 0.07 0.32 
pAR060302_0128 hypothetical protein 2.01 2.55 1.42 -0.29 0.01 
pAR060302_0129 hypothetical protein 2.08 2.84 1.93 -0.04 0.57 
pAR060302_0130 hypothetical protein 1.59 2.09 1.20 -0.08 0.26 
pAR060302_0131 hypothetical protein 2.11 2.64 1.95 -0.14 1.85 
pAR060302_0132 primase-helicase family member protein 1.72 2.65 1.73 -0.41 1.45 
pAR060302_0133 hypothetical protein 1.86 2.67 1.93 0.05 1.72 
pAR060302_0138 IntI1 -0.50 -1.60 -1.91 -0.94 0.67 
pAR060302_0142 chaperonin GroEL 0.86 -1.23 -0.05 1.98 2.09 
pAR060302_0143 ISCR16 InsE 0.58 -0.40 1.59 2.65 2.31 
pAR060302_0145 QacEΔ1 -2.74 -3.77 -4.14 -2.69 -3.15 
pAR060302_0146 Sul1 -3.03 -4.21 -4.61 -2.47 -4.29 
pAR060302_0147 hypothetical protein -2.23 -3.87 -3.70 -1.74 -4.35 
pAR060302_0149 IS1326 IstB -3.71 -2.17 -2.27 0.20 -1.33 
pAR060302_0150 IS1326 IstA -1.61 -1.87 -1.55 0.73 -0.10 
pAR060302_0154 IS26 -2.41 -3.04 -3.04 -2.77 -1.76 
pAR060302_0155 IS26 -1.69 -2.09 -2.30 -2.09 -0.73 
pAR060302_0158 transcriptional regulator MerD -0.71 -0.25 0.78 1.62 2.46 
pAR060302_0160 putative mercuric reductase -0.30 -1.01 0.36 0.88 1.88 
pAR060302_0163 putative transcriptional regulator MerR 0.71 0.10 1.56 1.12 2.39 
pAR060302_0165 hypothetical protein -1.89 -0.20 -0.32 -0.19 -2.24 
pAR060302_0171 hypothetical protein -0.84 -1.39 2.48 -1.48 1.23 
pAR060302_0172 hypothetical protein -1.70 -1.47 2.45 -1.39 0.22 
pAR060302_0173 hypothetical protein -1.15 -1.49 2.13 -0.82 0.28 
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pAR060302_0174 site-specific recombinase -0.98 -1.54 1.96 -1.14 0.25 
pAR060302_0175 exonuclease family protein -0.91 -1.18 1.98 -0.91 -0.10 
pAR060302_0188 Acr2 -1.09 -0.70 -0.99 -2.56 -1.04 
pAR060302_0190 StbA 0.50 0.81 0.07 -2.13 -2.12 
 
logFC indicates the log2(fold-change). Boxes in gray indicate genes that were statistically significantly different compared the genes 
expression in AR060302 (FDR < 0.05). 
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Table 3. COGs enriched in differentially expressed genes from strains carrying 
pAR060302 compared to plasmid free strains.  
Downregulated COGs Upregulated COGs 
  
DH10B (n = 445) DH10B (n=370) 
  # of genes P-value   # of genes P-value 
Biological Process:     Biological Process:     
Protein binding 75 3.80E-23 Reponse to stimulus 56 3.70E-15 
Lyase activity 40 4.10E-09 Catabolic process 47 2.70E-13 
Active transmembrane transport 42 2.40E-06 Response to stress 40 8.70E-13 
Cellular Compartment:     Cellular Compartment:     
Plasma membrane 118 4.70E-10 Cytoplasm 94 1.50E-12 
Molecular Function:     Molecular Function:     
Metal ion binding 66 7.30E-05 Metal ion binding 56 3.70E-06 
Cell surface activity 7 3.50E-04 Glycolate dehydrogenase activity 3 3.50E-05 
rRNA binding 6 8.90E-04 Unfolded protein binding 4 2.90E-02 
MH16125 (n = 24) MH16125 (n =72) 
  # of genes P-value   # of genes P-value 
Biological Process:     Biological Process:     
Nitrate metabolic process 3 3.40E-04 Localization 17 5.50E-03 
Oxidation reduction 8 6.00E-04 Ion transport 7 8.20E-03 
Cellular respiration 3 1.80E-02 Pathogenesis 4 9.40E-03 
Cellular Compartment:     Cellular Compartment:     
Nitrate reductase complex 4 1.50E-05 Plasma membrane 14 6.20E-04 
Molecular Function:     Molecular Function:     
Oxidoreductase activity 5 2.70E-07 Transporter activity 14 7.10E-03 
Formate dehydrogenase activity 3 4.00E-04     4.00E-04 
Metal binding 4 4.10E-02     4.10E-02 
SL317 (n = 154) SL317 (n = 160) 
  # of genes P-value   # of genes P-value 
Biological Process:     Biological Process:     
Locomotion 28 3.90E-28 Histidine biosynthesis 8 2.90E-09 
Pathogenesis 26 1.90E-23 Ketone metabolism 21 1.10E-05 
Chemotaxis 19 2.60E-17 Cellular biosynthetic process 35 1.70E-02 
Cellular Compartment:     Cellular Compartment:     
Flagellum 24 4.50E-24 Cytoplasm 25 3.40E-03 
Molecular Function:     Molecular Function:     
Motor activity 8 3.50E-10 Metal ion binding 22 8.70E-05 
Structural molecule activity 9 3.90E-05 Lyase activity 12 9.80E-03 
Unfolded protein binding 4 1.10E-03 Petosyl transferase activity 4 3.40E-03 
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Downregulated COGs Upregulated COGs 
SL486 (n = 245) SL486 (n = 73)  
  # of genes P-value   # of genes P-value 
Biological Process:     Biological Process:     
Pathogenesis 13 2.50E-06 Localization 20 1.90E-03 
Cellular catabolic process 16 8.30E-06 Transporter activity 20 1.90E-03 
Carbohydrate transport 21 4.10E-03 Siderophore transport 3 3.80E-03 
Cellular Compartment:     Cellular Compartment:     
Cytoplasm 34 9.90E-03 Plasma membrane 13 6.70E-03 
Molecular Function:     Molecular Function:     
Oxidoreductase activity 38 1.40E-04 Iron ion transport 5 5.50E-05 
Transporter activity 46 4.60E-03       
Unfolded protein binding 4 5.00E-03       
MR-1 (n = 269) MR-1 (n = 169) 
  # of genes P-value   # of genes P-value 
Biological Process:     Biological Process:     
Oxidation reduction 40 4.50E-12 Generation of precursor metabolites 15 4.70E-04 
Anaerobic respiration 15 5.10E-10 Iron ion homeostasis 4 1.30E-03 
Cellular respiration 22 1.00E-08       
Cellular Compartment:     Cellular Compartment:     
Formate dehydrogenase complex 8 2.10E-05 N/S     
Molecular Function:     Molecular Function:     
Iron binding 36 1.80E-15 Metal binding 21 5.40E-03 
Electron carrier activity 37 9.70E-14 Lyase activity 10 1.10E-02 
Oxidoreductase activity 55 6.50E-13       
Number of genes entered in each analysis are indicated. P-value is based on significance 
testing of enrichment based on total number of genes involved in each COG. N/S – Not 
significant. 
 
Specific pathways up-regulated in cells bearing pAR060302. The two main 
functional classes of genes upregulated in DH10 in response to carriage of pAR060302 
were those involved in two-carbon and fatty acid metabolism and amino acid degradation 
(Figure 8). All genes involved in glyocolate metabolism (glcDEFGBA) and glyoxylate 
cycle (aceBAK) were up-regulated in DH10. These two operons can be induced by either 
acetate or glycolate and are used to replenish pools of TCA cycle intermediates lost due 
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to synthesis of amino acids (85). Similarly, in the case of MR-1, which lacks the glc 
operon, genes in the glyoxylate cycle are up-regulated (aceBAK). Other genes involved 
with acetate production were also up-regulated (pta and ackA). MH16125 exhibited 
increased expression of genes involved in transportation across the cell membrane and 
those involved with pathogenicity. Some of the transport genes are involved with 
movement of carbon sources (wza, glpF, glpT and proV). The other genes are all located 
on pathogenicity islands and are involved in type three secretion (ssaJ, ssaK, ssaL, invH 
and sicP), inter-macrophage survival (mgtB and mgtC), and iron uptake (iroN). SL486 
and MR-1 also up-regulated iron transport genes, although these are not associated with 
pathogenicity. SL317 exhibited increased expression of several amino acid biosynthesis 
genes as well as genes involved in metabolism of alternative carbon sources such as 
propionate (prpR and prpE).   
 
  48 
Figure 8. Differential expression data from strains DH10 and MR-1 overlaid onto the 
glyoxylate bypass pathways. Data were analyzed as described in the Materials and 
Methods. Values given as log2(fold-change). All values had an adjusted p-value of < 
0.05. 
 
Specific pathways down-regulated in cells bearing pAR060302. Several genes 
involved in the biosynthesis of various amino acids were down-regulated in DH10. Also, 
the citCDEFXG operon, which converts malate into acetate and oxaloacetate, was down-
regulated. In MH16125, two operons involved in anaerobic respiration were down-
regulated in response to plasmid carriage (fdnI, fdnH, fdnG, narH, narJ, narG). Several 
homologs of these anaerobic respiration genes were also down-regulated in MR-1. 
Whereas in strain MH16125 a few genes involved in pathogenesis were up-regulated, in 
SL317 and SL486 several genes spanning multiple pathogenicity islands were down-
regulated. The functions of these genes include both invasion and type III secretion. In 
strain SL317 many genes involved in chemotaxis and motility were also down-regulated. 
 
Summary of changes to S. oneidensis megaplasmid due to carriage of 
pAR060302. S. oneidensis strain MR-1 stably maintains a 161,613 bp plasmid termed a 
“megaplasmid” (86). We mapped the transcriptome of MR-1’s megaplasmid in strains 
with and without plasmid pAR060302 (Figure 9). Surprisingly, the MR-1 strain used 
suffered a ~12 kb deletion which encodes several megaplasmid genes including that of 
repA. This could mean either 1) the plasmid has integrated into the genome of MR-1 or 
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2) the megaplasmid still exists as an extrachromosomal element that replicates via some 
alternative mechanism. Regardless, much of the gene content in our MR-1 strain 
remained. Table 4 indicates megaplasmid genes that were significantly differentially 
expressed when pAR060302 was present. Remarkably, few changes were observed, but 
of those few changes was an up-regulation in genes involved in toxin secretion. 
 
Figure 9. Transcriptome map of S. oneidensis megaplasmid in MR-1 with and without 
pAR060302. The rings from outside-in: 1) plasmid base pair coordinates (red indicating 
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possible deletion); 2) gene map of the megaplasmid; 3-4) transcriptome maps of the 
megaplasmid in strain MR-1(pAR) (green) and MR-1 (red). Genes on the map are 
colored by function: gray, hypothetical protein; yellow, mobile genetic elements; light 
purple, recombination; orange, replication; red, plasmid partitioning; light blue, DNA 
restriction/modification; purple, toxin/antitoxin; blue, bacterocin related; green, 
lipoprotein; dark red, metal efflux; dark yellow, transcriptional regulator.  Line plots 
represent average reads aligned to 250 bp windows along the megaplasmid, normalized 
for sequencing library size and log-transformed. Each line on the transcriptome maps 
represents 1.0 log. 
Discussion 
 
The purpose of this work was to characterize how the acquisition of broad-host-
range IncA/C plasmid pAR060302 might change the transcriptional network within the 
host cell. In addition, we were interested in how the host chromosome might influence 
the transcription of genes on the plasmid. Analysis of the transcriptome map of 
pAR060302 revealed that there are chromosome-plasmid interactions that are specific for 
individual genomes. It is interesting that in all but one strain, the IS26 transposase gene is 
down-regulated compared to that of its expression in wild-type strain AR060302. This 
suggests that IS26-mediated gene shuffling might play a significant role in genetic 
rearrangements in the host strain. Unfortunately there were not more E. coli strains used 
as hosts in our experiments as this may be a phenomenon specific to IncA/C plasmid 
carriage by E. coli. This, in part, could explain the vast amount of genetic rearrangements 
that define the IncA/C plasmid type (16, 23). The differential expression in genes 
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ORF0099-0133 on pAR060302 observed in strain SL486 and, in part, MR-1 and DH10, 
is curious as the genes in this region have received relatively little attention concerning 
their biological roles. Once thought to be completely conserved, as more IncA/C 
plasmids have been sequenced this has proven not to be true (87). More work focused on 
the molecular function of genes in this region is needed to further elucidate the role they 
play in the biology of this plasmid type.  
 
In order to analyze changes in chromosomal gene expression conferred by 
acquisition of plasmid pAR060302 we compared the transcriptomes of five strains with 
and without the plasmid. We used gene ontology analysis to distill meaning from large 
lists of differentially expressed genes. It is clear that plasmid acquisition is altering the 
energy flux of the cell. This has been reported elsewhere, primarily in the biotechnology 
literature (84, 88). These studies suggest that plasmid containing cells require more 
oxygen and increase the rate of glucose uptake in order to generate the additional ATP 
needed to replicate the plasmid, and to express any genes that may be present on the 
plasmid. In the present study, all strains were grown in LB broth, which is nutritionally 
rich, but does not contain glucose. The vast array of carbon-containing compounds 
available to cells may explain why expression of genes involved in metabolism was 
altered, but with no clear pattern when comparing all of the strains. Strains DH10 and 
MR-1 shared up-regulation of genes involved in glycolate metabolism and the glyoxylate 
bypass. These pathways are used to generate precursors for the TCA cycle (85). 
Conversely, the majority of the genes is these pathways were unchanged in the 
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Salmonella strains tested in this study. Both MR-1 and MH16125 showed down-
regulation of anaerobic metabolism genes, which suggests that IncA/C plasmid 
acquisition might also influence oxygen flux, but that the rate might be dependent on the 
host chromosome. Strain-specific metabolic effects has been reported for plasmid 
containing strains (84). These previous studies examining the effects of plasmid carriage 
on host metabolism have primarily been conducted using small cloning vectors. Many of 
the differentially regulated metabolic pathways conflict with the results that we observed, 
indicated that there are likely plasmid-specific influences on the host chromosome. There 
is a clear need for understanding how large plasmids, such as IncA/C, with many genes 
of unknown function, might be affecting host metabolism. Future experiments should 
focus on strictly defined media to better understand utilization of specific carbon sources. 
Work in this area might help elucidate new barriers to host range or explain fitness 
landscapes in natural environments.  
 
In our experiments, many genes located on pathogenicity islands in Salmonella 
were differentially expressed upon acquisition of pAR060302. These effects were not 
consistent across all strains of Salmonella. Two studies have demonstrated the ability of 
IncA/C plasmids to mobilize genomic islands located on the Salmonella genome (35, 89). 
Carraro et al. confirmed that this is due to the positive regulators of IncA/C conjugative 
transfer, AcaDC. It remains to seen whether or not IncA/C plasmids might also encode 
regulators that could alter pathogenic phenotypes, such as invasion or secretion. The 
activation or repression of virulence genes could be tied to other plasmid functions, such 
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as replication. The scenario where a plasmid that confers resistance to multiple 
antibiotics, and also alters expression of virulence genes, is truly an alarming one. Future 
work is needed to further characterize the myriad of putative transcriptional regulators 
encoded on IncA/C plasmids. 
 
Changes to host metabolic pathways observed in the present study beg the 
question: are these changes merely due to new energy requirements associated with 
plasmid acquisition or are they due to specific interactions of genes encoded on the 
plasmid directed at altering host gene expression? Plasmid pAR060302 carries several 
interesting hypothetical proteins that could directly mediate such interactions with 
chromosomal metabolic pathways: ORF0053 shares similarity to MhpR, an activator of 
phenylpropionate degradation; ORF0108 shares similarity with BglG (BglC), an activator 
of the sugar-transporting phosphotransferase bgl operon; and ORF0112 shares similarity 
to iron-sulfur cluster proteins involved in electron transport. Other plasmid types have 
been shown to encode novel catabolic proteins (90). It is tantalizing to consider that 
IncA/C plasmids may carry genes that might finely tune host metabolic pathways to 
reduce their fitness burden. More molecular genetics based experiments will be needed to 
clearly define the function of these putative protein and substantiate these broad ideas. 
 
Materials and Methods 
 Bacterial strains and growth conditions. The bacterial strains used were as 
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follows: Escherichia coli strain DH10B (DH10), E. coli strain AR060302 (AR060302) 
(15), Salmonella. enterica serovar Newport strain SL317 (SL317) (14), Salmonella. 
enterica serovar Heidelberg strain SL486 (SL486) (14), Salmonella enterica serovar 
Enteritidis strain MH16125 (MH16125) (14), and Shewanella oneidensis strain MR-1 
(MR-1) (86). A nalidixic acid resistant mutant of each strain (except for DH10 
(rifampicin resistant) and AR060302) was selected and used as a plasmid host. Plasmid 
pAR060302 was moved by conjugation into each strain, except AR060302, which 
already harbors the plasmid. Successful transconjugants were selected for using DifcoTM 
Luria-Bertani (LB) agar amended with either naldixic acid (30 ug/mL) or rifampicin (100 
ug/mL) and florfenicol (16 ug/mL). All strains were grown in 10 mL LB broth aliquots at 
37° C with shaking (200 RPMS), except MR-1, which was grown at 30° C, until an 
OD600 of 0.5 was achieved. Cells were pelleted and RNA was purified using a 
commercially available RNA extraction kit (Qiagen). Treatments were included to 
remove DNA contamination (Qiagen) and ribosomal RNA (MicrobExpress, Ambion). 
Two biological replicates for each strain were pooled for paired-end library sequencing 
(either 50 or 100 bp reads) via Illumina Genome Analyzer II at the Biomedical Genomics 
Center at the University of Minnesota. The details of each sequencing run and subsequent 
read mapping are reported in Table 4. All of the sequencing data are publically available 
under the NCBI BioProject ID PRJNA273283. 
RNA-Seq Analysis. All Perl scripts and other computational biology resources 
used in this study can be found at https://github.com/kevinslang. cDNA reads were first 
trimmed so that the quality at each base position was above 30 and then mapped to the 
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appropriate genome or plasmid sequence (for pAR060302, GenBank accession no. 
NC_092692, for DH10, the E. coli K-12 MG1655 published sequence was used GenBank 
accession no. NC_000913, for all S. enterica strains the LT2 published sequence was 
used, GenBank accession no. NC_003197, for S. oneidensis, GenBank accession no. 
NC_004347 and its megaplasmid, GenBank accession no. NC_004349). Read mapping 
was done using BOWTIE (67). For each host, transcriptome maps of pAR060302 were 
constructed using Circos (91). To achieve this, a table was generated containing the 
average number of reads mapped per 250 bp of plasmid sequence. Each average was then 
normalized per 1 million total reads in the cognate sequence library. These averages were 
then log transformed and plotted as a line plot. 
Table 4. Details of RNA-Seq reads obtained.  
Strain 
Number of 
Reads 
Read 
size 
Accession 
Number 
Mapped to 
Genome 
Mapped to 
pAR 
DH10 1.94E+07 100 bp SRR1768060 1.60E+07 N/A 
DH10(pAR) 1.49E+07 100 bp SRR1768074 1.40E+07 9.90E+04 
SL317 1.44E+07 100 bp SRR1768368 1.30E+07 N/A 
SL317(pAR) 1.32E+07 100 bp SRR1768369 1.20E+07 1.30E+05 
SL486 2.58E+07 50 bp SRR1768404 2.30E+07 N/A 
SL486(pAR) 3.32E+07 50 bp SRR1768405 3.00E+07 1.80E+05 
MH16125 2.20E+07 50 bp SRR1769820 2.00E+07 N/A 
MH16125(pAR) 3.00E+07 50 bp SRR1769821 2.80E+07 2.10E+05 
MR-1 4.40E+07 100 bp SRR1772150 4.30E+07 N/A 
MR-1(pAR) 4.20E+07 100 bp SRR1772169 4.00E+07 1.10E+05 
AR060302 4.00E+07 100 SRR1772148 N/A 3.30E+05 
 For statistical testing of differentially expressed genes, the total number of reads 
mapped to each coding sequence (CDS) was calculated using Perl. These values were 
then analyzed using the R package EdgeR (92, 93). We conservatively estimated the 
dispersion at 0.001. A fold-change cutoff of > 2 or < -2 and an adjusted p-value of < 0.05 
were used to define significantly differentially expressed genes. Clusters of orthologous 
groups (COGs) analysis was done using the online tool DAVID (82, 83). 
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Chapter 4 
A model for the regulation of IncA/C plasmid 
conjugation 
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Summary 
Conjugation plays a large role in the horizontal movement of DNA between bacteria 
species and even genera. Large conjugative plasmids in Gram-negative bacteria are 
associated with multi-drug resistance and have been implicated in the spread of these 
phenotypes to pathogenic organisms. IncA/C plasmids often carry genes that confer 
resistance to multiple classes of antibiotics. Although fully sequenced IncA/C plasmids 
have been described for almost a decade, many questions still remain concerning their 
basic biology. In this work, we investigated the function of genes that were involved in 
the regulation of IncA/C conjugation. We developed an IncA/C variant, pARK01, by 
removing resistance genes carried by the plasmid in order to make a suitable model for 
genetic based experiments. Using pARK01, we constructed additional mutations that 
show that acaDC encode positive regulators of conjugations. Furthermore, we conducted 
RNA-Seq and ChIP-Seq experiments to elucidate the regulon of acr2, an H-NS-like gene 
that is a negative regulator of conjugative transfer. This study begins to describe the 
functional roles of transcriptional activators encode by IncA/C plasmids and shows that 
these regulators may extend their function to genes encoded on the host chromosome.  
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Introduction 
 Several decades ago, IncA/C plasmids were observed in florfenicol-resistant 
bacterial isolates related to aquaculture farms in Asia receiving antibiotics (2, 94). 
Subsequently, the IncA/C plasmid type has spread globally and is now a major 
contributor to multidrug resistance in enteric pathogens (16, 22, 23, 26). Most studies, 
until recently, have focused on comparative genomics of these plasmids. These reports 
clearly showed that IncA/C plasmids carry a core set of backbone genes that are highly 
conserved (16, 19, 26). The functions of some IncA/C genes are easily assigned due to 
their similarity with genes of known function, particularly those involved with the type 
IV pilus and its assembly. However, there are numerous genes with similarity only to 
hypothetical proteins stored in GenBank databases. There have been no attempts to study 
these genes at a functional level and because of this very little is known about the 
mechanisms that are important for plasmid carriage and spread.   
  
 Regulation of SXT conjugation in Vibrio spp. SXT is an Integrative Conjugative 
Element (ICE) that is commonly found in Vibrio. SXT is closely related to IncA/C 
plasmids, in that they encode a similar type IV secretion apparatus used for conjugation 
as well as some antimicrobial resistance genes (21, 95). The regulation of SXT transfer 
has been investigated in detail (61, 62). SXT transfer is controlled primarily by three 
genes: setR, setC and setD (Figure 10). Under steady-state conditions, SetR negatively 
regulates a promoter upstream of setC and setD, PL (Figure 10a). SetR is susceptible to 
degradation by RecA, thus, during the SOS response when RecA becomes active within 
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the cell, SetR mediated repression of PL is relieved (Figure 10b).  
 
Figure 10. Model of SXT regulation of transfer. Adapted from (62). Red color indicates 
homology with flhDC. Blue color indicates predicted transglycosylase. Green color 
indicates homolog with cro. a) SetR represses at PL. b) During SOS response activated 
RecA degrades SetR. c) SetDC activates transcription of various promoters.  
 
SetC and SetD are homologous to FlhC and FlhD, respectively. FlhDC forms a complex 
that positively regulates motility in E. coli (96). Similarly, SetDC positively regulates 
several promoters on SXT, including those upstream of the genes that encode the 
conjugative transfer machinery (62) (Figure 10c). DNA damage is one of the stimuli that 
activate the SOS response in bacteria (62). Intuitively, during times of DNA damage it 
would be beneficial for the survival of a mobile element to transfer to neighboring cells. 
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IncA/C plasmids don’t encode a homolog of SetR, so their conjugative mechanisms may 
be regulated by a separate set of environmental stimuli. They do, however, encode 
homologs of SetD and SetC, AcrD and AcrC. The function of these proteins has only 
been inferred by comparative genomics and has not been tested experimentally.  
  
 H-NS-like nucleoid associated proteins. There are several nucleoid-associated 
proteins encoded by E. coli. H-NS is among the most well studied (97). H-NS binds 
preferentially to promoter sites upstream of genes and DNA with a low G + C content 
(98). These sequences serve as sites of initial binding. After these initial interactions, 
other copies of H-NS can bind to each other via protein-protein interactions, as well as 
the DNA, forming large complexes (98, 99). This is achieved through two distinct 
domains. The N-terminus of H-NS contains a oligomerization domain and the C-terminus 
contains a DNA binding domain (100). Primarily, H-NS binding results in silencing of 
adjacent gene transcription (101). Overcoming H-NS mediated silencing has been shown 
to be accomplished by binding of other proteins to the DNA, altering the topography 
(102).  
  
 Chromosomal copies of H-NS play an important role in regulation of horizontally 
acquired DNA, such as pathogenicity islands (103–105). In some cases, mobile elements 
encode their own copies of H-NS homologs (31, 33, 106). These horizontally encoded 
homologs of H-NS have been shown to antagonize the binding of the chromosomal 
copies of H-NS to horizontally acquired DNA (102, 107). These antagonistic H-NS 
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homologs have been found only on genomic islands of pathogenic E. coli, which makes 
sense, given their specific function. There have been a few studies focusing on plasmid 
encoded H-NS homologs (31–33, 108). H-NS homologs from plasmid pSfR27 and pCAR 
(Sfh and Pmr, respectively) seem to play roles in regulating a diverse set of genes, some 
of which are regulated by the chromosomally encoded H-NS copies (31–33). It has been 
proposed that uncontrolled expression of these genes, caused by plasmid acquisition, 
could lead to a reduction in fitness and subsequent loss of the plasmid from the 
population. The H-NS homolog encoded on the R27 plasmid of E. coli, H-NSR27, has 
been shown to directly interact with the plasmid’s origin of replication, oriT and other 
transfer associated genes to regulate conjugation (108). H-NSR27 was shown to be 
involved in an intricate interplay of chromosomally encoded H-NS homologs to 
thermally regulate the expression of the conjugative transfer apparatus of R27.  
 
 Aside from comparative analyses, no work has been done to elucidate the function 
of the transcriptional regulators encoded on IncA/C plasmids. In this study, we described 
the function of a cluster of transcriptional regulators. We found that three of these genes 
regulate conjugative transfer of IncA/C plasmids. One of these genes, acr2, encodes an 
H-NS homolog. RNA-Seq and ChIP-Seq were used to characterize Acr2 binding sites. 
Using site directed mutations, we found that Acr2 shares a DNA binding motif with that 
of other H-NS homologs and that this collection of amino acids is critical for its function 
as a repressor of conjugation.     
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Results  
Development of pARK01. A plasmid such as pAR060302 with its many antimicrobial 
resistance genes makes it difficult to study systematically using modern genetic 
techniques. The most common method for making deletions in E. coli is via site directed 
recombination using a dsDNA substrate (recombineering) (109). To prime cells for 
recombineering, a vector is commonly used, which also requires antimicrobial selection 
for its maintenance. We first set out to develop a derivative of pAR060302, lacking 
tetracycline and ampicillin resistance in order to obtain a prototypical IncA/C plasmid 
that could be used for more in depth genetic analysis. Figure 11 shows the schematic for 
deletion of tet(A), which confers tetracycline resistance. The details of this are described 
in detail in the materials and methods. Briefly, we used strain DY331, which carries the 
genes needed for recombineering on a stable prophage, circumventing our need for 
maintenance by antimicrobial selection. Subsequently we inserted a module conferring 
kanamycin resistance and a synthetically lethal copy of ccdB, a potent toxin, which is 
under control of a rhamnose-inducible promoter. This module allows for selection of the 
initial insertion and subsequent counter-selection of the removal of ccdB, allowing for 
repair of the insertion in any manner we choose using either a ssDNA or dsDNA 
substrate. In this case we chose to remove the module, leaving only the start and stop 
codon of tet(A) (Figure 11c). A similar strategy was used to eliminate the blaCMY-2 gene 
as well. Figure 11d demonstrates that the conjugation frequency of pARK01 is no 
different than that of the intact plasmid. Furthermore the conjugation frequency of 
pARK01 is similar to that of the WT strain AR060302 under laboratory conditions.  
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Figure 11. Development of pARK01. a) The neo-ccdB cassette was inserted into the 
tet(A) gene. The neo-ccdB cassette confers kanamycin resistance as well as lethality on 
minimal media plates with rhamnose used as the carbon source. b) A 70 nt ssDNA oligo 
was used to repair the neo-ccdB insertion in cells primed for recombineering. c) The 
repair makes a scarless mutation leaving behind only the start and stop codon of tet(A). d) 
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Conjugation experiment showing conjugation frequency of donor strains WT strain 
AR060302 (WT AR), K-12 strain MG1655 carrying pAR060302 (K12 pAR) and K-12 
strains MG1655 carrying pARK01 (K12 pARK01). The results represent the means and 
standard deviations of 3 experiments. 
  
 The genes acrD and acrC encode the positive regulators of IncA/C transfer. A 
cluster of predicted transcriptional regulators has been demonstrated to be conserved 
amongst all sequenced IncA/C plasmids (16). Given the similarity of the organization of 
these genes on IncA/C plasmids and SXT elements we investigated whether or not these 
genes were responsible for the control of IncA/C plasmid conjugation (Figure 12a). The 
putative orf183 of IncA/C plasmids shares homology only with hypothetical proteins. 
Some of these proteins are listed as having permease activity, but this is likely due to 
inadequate annotation. Although orf183 shares no amino acid similarity with SetR but 
because of its orientation and proximity to the other predicted transcriptional regulators, 
it may be negatively regulating conjugative transfer. Deletion of this gene does result in a 
slight increase in transconjugants, however not to the extent that would be consistent with 
it serving a role analogous to setR of SXT (Figure 12b). SetR is such a strong repressor of 
conjugation that deletion of the gene which encodes it is lethal (62). We found that this is 
not the case with orf183.  
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Figure 12. Regulation of conjugation locus of IncA/C plasmids. a) Gene map of the 
cluster of transcriptional regulators that regulate conjugation. Red indicates homology to 
flhDC. Green indicates predicted DNA binding domains. Blue indicates predicted 
transglycosylase activity. b) Conjugation frequency of mutants. Results represent mean 
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and standard deviation of 3 experiments. Means were compared using a 2-tailed 
Student’s T-test. * indicates p-value > 0.05. ** p-value < 0.05. c) Activity of promoter 
fusions to lux operon. Results represent mean and standard deviation of 3 experiments.  
 
 Given its similarity to the phage gene cro we predicted that acr1 would be involved 
in a negative feedback loop, limiting expression of genes involved in conjugation once 
they have been upregulated. This prediction turned out to be false, as a deletion mutant 
conferred no change in conjugative frequency (Figure 12b). Due to their similarity with 
SetDC encoded on SXT, we investigated whether AcrDC served a similar role as positive 
regulators for IncA/C plasmids. Indeed, deletion of these genes results in a plasmid 
devoid of transfer and over expression of these genes from an inducible promoter results 
in increased transfer frequencies (Figure 12b). To further investigate this phenomenon, 
we cloned promoters upstream of transfer-associated genes into a lux reporter vector. Our 
results demonstrate that AcaDC positively regulates these promoters (Figure 12c). The 
promoter upstream of orf190 is analogous to the promoter controlling the expression of 
the int gene in SXT. Curiously, in IncA/C plasmids, the int gene has been replaced by a 
gene encoding a putative H-NS-like NAP, acr2. Our results suggest that the same genes 
responsible for positive regulation of conjugation also positively regulate acr2. 
  
  
 
 
  67 
 
 
Figure 13. Conjugation frequency of acr2 mutants. Results represent the mean and 
standard deviation of 3 experiments. Means were compared using a 2-tailed Student’s T-
test. * indicates p-value > 0.05; *** indicates p-value < 0.05. 
 
 Acr2 is an H-NS-like protein that represses conjugative transfer of IncA/C 
plasmids. To further investigate the potential role of acr2 in the conjugative transfer of 
IncA/C plasmids, we generated a deletion mutant in pARK01 and conducted transfer 
experiments. Plasmids lacking acr2 exhibit a 10-fold increase in conjugation frequency 
compared to plasmids with no acr2 mutation (Figure 13). We were able to complement 
this phenotype by expressing acr2 cloned upstream of an arabinose inducible promoter in 
the vector pBAD22. The observation that acr2 negatively regulates conjugation 
corroborates our RNA-Seq results that show that nearly all of the genes that are predicted 
to be involved in conjugative transfer are up-regulated in the Δacr2 strain (Figure 14-4th 
ring). In addition to genes involved with transfer being up-regulated, the region 
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containing many hypothetical proteins and putative phage-like proteins (bp positions 
~82k-100k) were also up-regulated in our experiment.  
  
 Characterization of Acr2 binding sites. The vector used for arabinose inducible 
expression of acr2 was constructed in such a way that a polyhistidine epitope was affixed 
to Acr2. It was crucial that this epitope-tagged Acr2 was able to complement the mutant 
phenotype to WT levels. We made the assumption that because the complementation 
strain transfer frequency was not statistically different than that of the WT, Acr26xHis was 
likely binding to sites similar to that of the WT protein. This allowed us to perform a 
ChIP-Seq experiment in vivo. To better understand how acr2 was regulating conjugative 
transfer we used nickel affinity chromatography to pull down Acr26xHis cross-linked to 
DNA, which was subsequently sequenced. Analysis of the ChIP-Seq data revealed that 
Acr26xHis binds to several loci on the plasmid (Figure 14, rings 1 and 2). Some of the 
ChIP peaks overlapped with genes of unknown function, such as near base pair 
coordinates 19k, 45k, 140k, and 145k. The regions that showed greatest binding were the 
entire ISEcp1 region, the regions within the traFHG and the region upstream of acr1. 
Binding upstream of acr1 would suggest a direct repression of the operon encoding the 
positive regulators acrDC.  
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Figure 14. acr2 regulon in pARK01. Outer ring (Ring 1) Base pair coordinates of 
pAR060302. (Ring2) Results of ChIP-Seq experiment. Scale (toward the outer circle) is 
from 0 reads to 1500 on a linear scale. (Ring 3) Enriched peaks (purple bars) as found by 
MACS (110). (Ring 4) Differentially expressed genes in pAR060302Δacr2 compared to 
pAR060302. Color indicates fold-change and FDR < 0.05. Grey indicates unchanged. 
(Ring 5) pAR060302 gene map. Genes on the map are colored by function: gray, 
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hypothetical protein; red, antibiotic resistance; yellow, mobile genetic elements; green, 
transcriptional regulation; light purple, recombination; purple, DNA binding; blue, 
conjugal transfer; light blue, transglycosylase; orange, replication. (Ring 6) G+C content 
along 150 bp windows of pAR060302.  
 
 
Figure 15. Expression of E. coli chromosomal genes carrying either pAR060302 or 
pAR060302Δacr2. Normalized expression values were calculated using Perl and are 
displayed as Reads Per Kilobase of gene length per Millions of total reads (RPKM) on a 
log10 scale. Acr2 enriched peaks were found with MACS and annotated with BedTools.  
 
 Our ChIP data does suggest that Acr26xHis binds to chromosomal DNA sequences. 
However, like other H-NS-like proteins, the interactions are not easily interpretable. For 
example, we only found 3 instances of binding of genes that were subsequently found to 
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be significantly differentially expressed in our RNA-Seq data (Figure 15). Interestingly, 
all three of these genes have to do with metabolism, most notably the glcB gene which is 
in the an operon that was discussed in Chapter 3 as being up regulated in E. coli carrying 
pAR060302, compared to cells lacking the plasmid. 
 
 We used MACS (Model-based Analysis of ChIP-Seq) (110) to determine 
significantly enriched peaks in DNA pulled down with Acr26xHis. The Sequence 
surrounding the summits of each of the significant ChIP peaks found by MACS was 
submitted to MEME (Multiple Em for Motif Elicitation) to determine if there were 
common motifs within the significant peaks. The motif discovered in a majority of the 
peaks is A+T rich, similar to that of other H-NS-like proteins (Figure 16b). We used 
EMSA to confirm that Acr26xHis binds to the DNA fragment upstream of acr1 containing 
the motif, but not a different A+T rich promoter sequence (Figure 16a). Analysis using 
the tool Bprom (111) to computationally predict bacterial promoters shows a predicted 
transcriptional start site 287 bp upstream of the start codon of acr1 (Figure 16c). If this 
prediction is correct, 5’ end of the acr1 transcript could conform to a highly structured, 
stable secondary structure as predicted by our Mfold (112) analysis (Figure 17). These 
results provide evidence that Acr2 directly represses transcription of the operon 
containing acrDC by binding to the sequence upstream of acr1.  
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Figure 16. Acr2 binds promoter region of acr1. a) Electromobility Shift Assay using 
either a fragment of DNA upstream of acr1 (left) or floR (right) combined with either no 
protein, or increasing protein concentrations of 150 nM, 200 nM, 300 nM, 400 nM, 500 
nM, 600 nM, 700 nM, or 850 nM. DNA-protein complexes were separated on a 7.5 % 
native acrylamide gel. The black triangle indicates a bound DNA complex. b) Consensus 
DNA binding sequence of Acr2 as found by MEME (113). 200 bp of sequence 
surrounding each peak summit found by MACS and compared by MEME. c) Promoter 
region of acr1 323 bp upstream of acr1 start codon. -35, -10 and TSS sites indicated were 
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predicted by bprom (114). The underlined sequence is the predicted binding site of Acr2.   
 
 
 
Figure 17. Predicted secondary structure of the 5’ end of the predicted acr1 transcript. 
323 bp of sequence upstream of the acr1 start codon was submitted to Mfold online 
prediction tool (112). The resulting structures all had a ΔG ~ 73 kcal/mol at 37° C. 
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Figure 18. Development of Acr2 variants. a) Alignment of the C-terminal domain of 
Acr2 and other H-NS-like proteins. Box indicates region of conserved amino acid 
positions. Red letters indicate the AT hook motif in Acr2. b) The neo-ccdB cassette was 
inserted into the the 3’ end of acr2 via recombineering. c) a 70 nt ssDNA oligo was 
electroporated into cells primed for recombineering to excise the neo-ccdB cassette and 
replace it with the sequence of acr2 containing nucleotide changes needed to achieve the 
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proper (d) amino acid substitutions. 
  
The C-terminal domain of Acr2 is crucial for its activity. The C-terminal domain of 
Acr2 is similar to that of other H-NS-like proteins (Figure 18a). It contains the Q/RGR 
motif that has been shown in structure studies to be critical to contact with DNA (115). 
We examined the possibility that this motif was important for Acr2 activity by making 
mutations in this region using recombination with a ssDNA substrate (Figure 18b, c, and 
d, detailed in Materials and Methods). An in-frame deletion of the codons for QGRRPD 
resulted in abolishment of the ability of Acr2 to repress conjugative transfer (Figure 19a). 
Although substitution of alanine for glutamine at position 116 resulted in increased 
transfer frequency, it was not as a dramatic as the increase observed for alanine 
substitutions for the arginine residues at positions 118 and 119 (Figure 19a). Given that 
these substitutions could have led to proteins targeted for degradation, which could also 
explain the acr2- phenotypes observed, we cloned each of these Acr2 variants in an 
arabinose inducible vector. We used these constructs to test the ability to repress the 
LacZ activity of an acr1-lacZ fusion construct (Figure 19b). Only the WT Acr2 and the 
Q116A variant were able to repress LacZ activity. The Q116A result contrasts with that 
of the conjugation experiment. In the conjugation experiment the Acr2 variants were 
under native promotion. This is probably much lower than that achieved by arabinose 
induction of the pBAD vector, however, we cannot rule out the possibility of degradation. 
Taken together, these results suggest that the QGRR motif is critical for the ability of 
Acr2 to repress the promoter upstream of acr1.  
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Figure 19. Activity of Acr2 variants. a) pARK01 encoding variants of Acr2 were used in 
conjugation experiments. Results represent the mean and standard deviation of 3 
experiments. Green hashed line indicates the conjugation frequency of pARK01Δacr2. 
Black hashed line indicates the conjugation frequency of pARK01. b) Alleles encoding 
Acr2 variants were cloned into pBAD and assayed for their ability to repress a acr1-lacZ 
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fusion construct. Blue color indicates LacZ activity. White color indicates absence of 
LacZ activity.  
 
Discussion 
 IncA/C conjugation is regulated by several different transcriptional regulators. 
Figure 20 displays our proposed model for the regulation of transfer built from the results 
of our work, as well as others (19, 35). The results of this work demonstrate that Acr2 
represses conjugative transfer. We showed that this is, at least in part, due to a direct 
interaction between Acr2 and the sequence upstream of acr1. During the preparation of 
this manuscript, Carraro et al. also showed this interaction using a different IncA/C 
plasmid isolated from Vibrio cholera (35). Our ChIP-Seq data suggest that Acr2 binds 
upstream of other genes that are predicted to be important for transfer, namely traF and 
traG. There are a few hypothetical proteins that are annotated on IncA/C plasmids that 
are located near or within the transfer-associated loci. For example, orf97 and orf98 are 
located just downstream of traN, both of which have no known function nor are similar to 
any protein sequence with known functions in GenBank. We found a ChIP-Seq peak on 
the 3’ end of traN near orf97. It is difficult to understand the function of such an 
interaction due to the ambiguity of purely hypothetical proteins such as orf97.  
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Figure 20. Proposed model for the regulation of IncA/C conjugation. Red indicates 
homology to flhDC. Green indicates predicted DNA binding domains. Blue indicates 
predicted transglycosylase activity. Acr2 and Acr1 have been shown to repress Pacr1 and 
orf183 represses conjugation by some unknown mechanism. Expression of acaDC results 
in the up-regulation of transfer genes as well as mobilization of other genomic islands. 
This also may express acr2, which, in turn, shuts down conjugation. Acr2 acts on other 
loci on the plasmid including on genes of unknown function and newly acquired DNA.  
 
 There are other mechanisms that contribute to the repression of conjugation. In this 
work we found that orf183 represses conjugation by a mechanism that is unclear. The 
predicted protein sequence encoded by orf183 shares no similarity to proteins with 
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known functions in protein databases. Certainly, more work needs to be done to 
understand the gene product of orf183 to understand if its role is truly to act as a 
repressor of conjugation. In our experiments, acr1 deletion did not exhibit an effect on 
conjugative transfer. This contrasts data recently published showing that Acr1 represses 
conjugation and directly binds the sequence upstream of acr1 (35). We still wonder if 
there might be another factor involved in repressing conjugation of IncA/C plasmids. The 
setR gene of SXT is a strong repressor of conjugation, so much so that its deletion is 
lethal (62). None of the known repressors of IncA/C transfer, described in this work or 
elsewhere, exhibit this phenotype. Furthermore, SetR acts as a proxy for detecting DNA 
damage. Intuitively, if the cost of conjugation is so high, one would conclude that it must 
be turned on only when needed.  
 
 We have shown that conjugation requires the activators AcaDC. This has been 
described elsewhere and, similar to homologous FlhDC, AcaDC has been shown to form 
a multimeric complex (35). Our experiments also demonstrate that conjugation 
frequencies can reach high levels when acrDC is over expressed, indicating that the 
strength of transcription of the operon containing them is still a limiting factor in acr2 
mutants. It is also possible that post-transcriptional regulation plays a role. Our 
computational approaches to predict the TSS suggest that it is several hundred base pairs 
upstream of the acr1 start codon and that the resulting mRNA could be highly structured. 
The secondary structure of the untranslated portion of this mRNA could be important for 
regulation of its translation (65). Surely overexpression of this activity might have 
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negative consequences for the host bacterium. Both our results and those of others (19, 
35) begin to paint a picture of how IncA/C plasmids fit in existing regulatory networks 
encoded by the host chromosome. 
 
 Acr2 is an H-NS-like protein that binds several sites on IncA/C plasmids. Our 
results demonstrate that, like other H-NS homologs, Acr2 binds A+T rich DNA, but that 
it also has a propensity to bind a specific signature (98, 99). It has been proposed that the 
amino acid composition in the AT hook motif is the mechanism by which different H-NS 
homologs distinguish between chromosomal and horizontally acquired DNA (115). It is 
thought that the number or arrangement of positively charged amino acids, such as 
arginine, determine the DNA recognition by H-NS-like proteins. Acr2 shares a DNA 
binding motif with that of other H-NS homologs and our results show that this set of 
amino acids is critical for its function. The AT hook motif in Acr2 contains an addition 
arginine residue (R119) that is not observed in other H-NS homologs. We have shown 
that this arginine is important for the function of Acr2. This difference might result in 
Acr2 having a distinct propensity to bind specific regions of IncA/C plasmids to 
accomplish specific tasks, such as repressing conjugation.  
 
 Other roles for Acr2. We have generated, at the very least, circumstantial evidence 
that Acr2 might have other roles in the biology of IncA/C plasmids. Our ChIP-Seq data 
suggest that Acr2 binds nearly the entire ISEcp1 element that carries the blaCMY-2 gene. 
Comparative genomics studies have demonstrated that the acquisition of this transposon 
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is a recent event in the evolution of IncA/C plasmids (16, 23, 26). Is it possible that Acr2 
binds newly acquired mobile elements on IncA/C plasmid backbones? Given the 
propensity for H-NS to bind genomic islands, it is seems plausible (101). Furthermore, 
Acr2 binds to the 3’ end of the rhs gene located downstream of the class 1 integron (bp 
coordinate ~146,000). The rhs genes have repeat sequence elements that implicates them 
in genome shuffling (116). A recent work from Harmer et al. suggests that the rhs 
homolog carried on IncA/C plasmids plays an important role in the diversity of newly 
integrated mobile elements (26). Could binding by Acr2 inhibit the ability for 
recombination to happen at the rhs locus? H-NS has recently been shown to play an 
important role in the evolution of Salmonella, providing stability for its genomic islands 
(104). Given broad spatial distribution of highly similar variants of IncA/C plasmids, 
there must be several mechanisms driving their evolution. 
 
 Our ChIP-Seq experiment also yielded evidence that Acr2 binds chromosomal 
DNA. It is unclear what the true role of this binding is as nearly all genes bound showed 
no differential expression in RNA-Seq experiments. It will take more sophisticated 
experiments to tease out the meaning behind these results. There were three bound genes, 
however, that were differentially expressed in our RNA-Seq data. All three have to do 
with different metabolic pathways. Interestingly, one of the genes is glcB, which is 
involved in the glyoxylate bypass pathway discussed in Chapter 3. This lends some 
credence to the ideas posed in Chapter 3 detailing the possibility that IncA/C plasmids 
encode the ability to specifically alter host metabolic pathways to improve fitness of 
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plasmid carrying cells. This presents an almost phage-like scenario where the plasmid co-
ops the host bacterium to become adept at carrying and disseminating the plasmid. It is an 
exceedingly interesting area of study that future work must explore.  
  
Materials and Methods  
 Bacterial strains, plasmids and growth conditions. The bacterial strains and 
plasmids are listed in Table 5. All strains were routinely grown in Difco™ Luria-Bertani 
(LB) broth or LB agar at 37° C unless otherwise noted. Broth cultures were grown in a 
shaking incubator at 37° C with shaking (200 RPM) unless otherwise noted. 
Supplementation of ampicillin (Amp, 100 µg/mL), chloramphenicol (Cm, 20 µg/mL), 
nalidixic acid (Nal, 30 µg/mL), kanamycin (Kan, 100 µg/mL), rifampicin (Rif, 100 
µg/mL) and tetracycline (12.5 µg/mL) were used as needed. Counter-selections were 
done using M9 minimal agar was supplemented with 0.2% rhamnose. Arabinose 
induction of pBAD22 vector constructs was achieved with a final concentration of 0.02 
%. X-gal was added to agar plates at a concentration of 40 µg/mL. Diaminopimelic acid 
(DAP) was add to a final concentration of 300 µM to facilitate growth of WM3064. 
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Table 5. Strains and plasmids used in this study. 
Strain or Plasmid  Characteristics Source 
E. coli DH10B RifR strain used as a conjugation recipient Lab stock 
E. coli MC4100 lac- strain used for observing LacZ fusion activity Lab stock 
E. coli K12 MG1655 Model E. coli strain Lab stock 
E. coli DY331 E. coli with stable prophage that expresses beta-gam-exo (117) 
E. coli WM3064 dapA auxotroph Lab stock 
E. coli WM3064nalR nalR mutant of WM3064 This work 
E. coli AR060302 Wild type host of pAR060302 (15) 
pAR060302 IncA/C plasmid, FloR, CmR,  (15) 
pARK01 pAR060302 derivative carrying deletion of tetA and blaCMY-2 This work 
pARK01-01 pARK01 carrying deletion of orf183 This work 
pARK01-02 pARK01 carrying deletion of acr1 This work 
pARK01-03 pARK01 carrying deletion of acaDC This work 
pARK01-04 pARK01 carrying deletion of acr2 This work 
pARK01-05 pARK01 carrying lacZ fusion of the first 4 codons of acr1 and lacZ and a deletion of acr2 This work 
pARK01-06 pARK01 carrying the Acr2ΔAThook mutation This work 
pARK01-07 pARK01 carrying the Acr2(Q116A) mutation This work 
pARK01-08 pARK01 carrying the Acr2(R118A) mutation This work 
pARK01-09 pARK01 carrying the Acr2(R119A) mutation This work 
pARK01-10 pARK01 carrying the Acr2(R118A and R119A) mutation This work 
pBBRLux Plasmid carrying a promoterless lux operon; CmR (118) 
pLux pBBRLux with tetRA in place of cat This work 
pLuxFloR pLux with floR promoter cloned in between SpeI and BamHI sites This work 
pLuxTraI pLux with traI promoter cloned in between SpeI and BamHI sites This work 
pLuxTraF pLux with traF promoter cloned in between SpeI and BamHI sites This work 
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pLux190 pLux with orf190 promoter cloned in between SpeI and BamHI sites This work 
pBAD22 arabinose inducible vector, AmpR (119) 
pB183 pBAD22 with orf183 cloned  This work 
pBacr2 pBAD22 with acr2 cloned  This work 
pBacaDC pBAD22 with acaDC cloned  This work 
pBacr2ΔAThook pBAD22 with acr2ΔAThook cloned  This work 
pBacr2Q116A pBAD22 with acr2Q116A cloned  This work 
pBacr2Q116A pBAD22 with acr2Q116A cloned  This work 
pBacr2R119A pBAD22 with acr2R119A cloned  This work 
pBacr2R118A,R119A pBAD22 with acr2R118A,R119A cloned  This work 
pCP20 plasmid expressing FLP recombinase, AmpR, ts rep (109) 
pSIM5-tet plasmid expressing beta-gam-exo used for recombineering, tetR (117) 
pKD4 plasmid carring FRT-neo-FRT cassette, KanR, AmpR (109) 
pKD45 plasmid carrying neo-ccdB cassette, R6K ori (117) 
 
Table 6. Oligonucleotides used in this study. 
Name Sequence 
pARdeltaTet-fw CCGGCATTCGCTGCGCTTATGGCAGAGCAGGGAAAGGAATTGCCGGGCTAGAGCCTGACATTTATATTCC 
pARdeltaTet-rv GGCTGCAACTTTGTCATGCTTGACACTTTATCACTGATAAACATAATATGGTCCCGCTCAGAAGAACTC 
deltaTetRepairOligo CTTATGGCAGAGCAGGGAAAGGAATTGCCGGGCTACATATTATGTTTATCAGTGATAAAGTGTCAAGCAT 
pARdeltaBlaCMY2-fw CTGACGGGCCCGGACACCTTTTTGCTTTTAATTACGGAACTGATTTCATGGAGCCTGACATTTATATTCC 
pARdeltaBlaCMY2-rv AAAAAAGAGAAAGAAAGGAGGCCCAATATCCTGGGCCTCATCGTCAGTTAGTCCCGCTCAGAAGAACTC 
deltaCMYrprOligo ACCTTTTTGCTTTTAATTACGGAACTGATTTCATGTAACTGACGATGAGGCCCAGGATATTGGGCCTCCT 
183_KOchk-F TCGACGGAAGCTGGAGACCGT 
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183_KOchk-R TGATGCCGTGGTAAACTGGAGGT 
183_koCHK-F CCGCGCAACGCGGATAAAGC 
183_koCHK-R GCTGGCTCCCTTCGGCGTTT 
pBAD22_orf183-rv ATTCCCAGAAGCACCATTCCCAGCAGAAGAATATTGACCACATGTTTCATGGTGAATTCCTCCTGCTAG 
pBAD22_orf183-fw ATTCCTATGATTTTGACCAGCGCTTCCATATTGGAGCTGGAGACGAATAAGTACCCGGGGATCCTCTAG 
pbadseq-2 GGCTGAAAATCTTCTCT 
pbadseq-1 CTGTTTCTCCATACCCGTT 
acr1_KO-F TGTATGGCTAACAACGCAGTTTAAAGGGTGGCAAACAATGGTGTAGGCTGGAGCTGCTTC 
acr1_KO-R GCCGCAGACAGAACTAGCGCCTTGGCTTTGTTCTTCATCAATGGGAATTAGCCATGGTCC 
acr1_KOchk-F ACAACGCAGTTTAAAGGGTGGCA 
acr1_KOchk-R GCCGCAGACAGAACTAGCGCC 
acaDC_KO-F ATCTATCGCAACCTTCGTGATTTGTGAGGGGGGCGGAATGGTGTAGGCTGGAGCTGCTTC 
acaDC_KO-R GGGCGCTCATCTTCTGGTCCGAAATGTCATAGTCTACTCAATGGGAATTAGCCATGGTCC 
acaDC_KOchk-F GCCGCTATCACGCCTGGGAA 
acaDC_KOchk-R GGGCGCTCATCTTCTGGTCCG 
pBAD22_acaDC-rv TGTCGAGCTGTAACCCAGCGACCCAATGTACCAGAGTTGCCAATGTTCATGGTGAATTCCTCCTGCTAG 
pBAD22_acaDC-fw TATTGAAAAAACTGCAACAGTCTCTACAGGGACGTGGGAGGTGGAGATGAGGCTGTTTTGGCGGATGAGA 
pBBR-F CGCGCGTAATACGACTCACT 
pBBR-R TCGGGAAAGATTTCAACCTG 
cat_frt-tet-frt-fw GACCGTTCAGCTGGATATTACGGCCTTTTTAAAGACCGTAGAATTCGAGCTCGGTACCCG 
cat_frt-tet-frt-rv ATTGGCTGAGACGAAAAACATATTCTCAATAAACCCTTTAGCTATGACCATGATTACGCC 
BamHI-190p-rv GGATCCATAACATGAAATCCTCCAAAGATT 
SpeI-190p-fw GATACTAGTTGCTGGAGGGCAAGCGGTTC 
BamHI-floRp-rv GGATCCATAACATGACGAATCAACCCTCG 
SpeI-floRp-fw GATACTAGTAAAGATAATCGGATAAAATG 
BamHI-traFp-rv GGATCCATAACACGTATTTTCCCATGCTCG 
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SpeI-traFp-fw GATACTAGTGGACACGACCAAATAGTTTG 
BamHI-traIp-rv GGATCCATAACATGTAGGTTGACCATATTC 
SpeI-traIp-fw GATACTAGTTCGTTCCTCATAAAAAATTG 
acr2_ko-F AGAAGATGAGCGCCCAAACTTTGCGGCGCTCATTTTTTTAGTGTAGGCTGGAGCTGCTTC 
acr2_ko-R GATTCACTTAAAGGAAAACTGATGGGCTCCGTATGACATGATGGGAATTAGCCATGGTCC 
acr2_chk-F AGGAAGGCATGGTGGTGGGGA 
acr2_chk-R ATTCGCCAGTGCAGACTGACGC 
pBAD22_acr2_6xhis-fw 
AGCTGTCGAGCTGGAGCGCTACCGTATCCCACAGAAGAAGCATCACCATCA 
CCATCACTAAGGCTGTTTTGGCGGATGAGA 
pBAD22_acr2-rv CAGCCGCTGATAGCGTAGAGAACTCCTCGTGGTCTTTCATGGTGAATTCCTCCTGCTAG 
acr1-EMSA-F CCCTAAAATCACTTATACC 
acr1-EMSA-R CAATTGGCATTTATCCATTG 
floRp-rv ACATGACGAATCAACCCTCG 
floRp-fw AAAGATAATCGGATAAAATG 
delATHOOKAcr2-kanccdB-fw CTCCAGCTCGACAGCTCCCAACCCCTTGAAAGCATCCGGGGTCCCGCTCAGAAGAACTC 
delATHOOKAcr2-kanccdB-rv ATTCAAAAGACGGAGTTTCGTGGAGTGGGCAAGGACGTCGGAGCCTGACATTTATATTCC 
delATHOOK-repair 
CGCTCCAGCTCGACAGCTCCCAACCCCTTGAAAGCCCCACTCCACGAAACTC 
CGTCTTTTGAATATTTAG 
Acr2Q116A 
CTAAATATTCAAAAGACGGAGTTTCGTGGAGTGGGGCGGGACGTC 
GCCCGGATGCTTTCAAGGGGTTGGGAGC 
Acr2R118A 
AATATTCAAAAGACGGAGTTTCGTGGAGTGGGCAAGGAGCGCGCC 
CGGATGCTTTCAAGGGGTTGGGAGCTGT 
Acr2R118A-R119A 
AATATTCAAAAGACGGAGTTTCGTGGAGTGGGCAAGGA 
GCGGCGCCGGATGCTTTCAAGGGGTTGGGAGCTGTCGA 
Acr2R119A 
ATTCAAAAGACGGAGTTTCGTGGAGTGGGCAAGGACGTG 
CGCCGGATGCTTTCAAGGGGTTGGGAGCTGTCGA 
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deltalacAY-fw GCCTGATAAGCGCAGCGTATCAGGCAATTTTTATAATTTAGTGTAGGCTGGAGCTGCTTC 
deltalacAY-rv CAGGCCATGTCTGCCCGTATTTCGCGTAAGGAAATCCATTATGGGAATTAGCCATGGTCC 
acr1-lac-rv TTTGGGCGCTCATCTTCTGGTCCGAAATGTCATAGTCTACCGTGTAGGCTGGAGCTGCTT 
acr1-lac1-fw AACAACGCAGTTTAAAGGGTGGCAAACAATGGATAAATGCCCCGTCGTTTTACAACGTCG 
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Strain construction via recombineering. All deletions and mutations were done via λ-
Red mediated recombination (recombineering) with some variations. Strain WM3064 
was grown at 37° C with shaking (200 RPM) in LB broth supplemented with DAP 
overnight. This culture was used to inoculate a new 10 mL LB+Dap broth culture, which 
was incubated for 4 hours at 37° C with shaking (200 RPM). The cells were pelleted by 
centrifugation at 8000 RPM for 10 minutes. The pellet was resuspended with 100 µL of 
LB broth and used to inoculate an LB agar plate supplement with Nal and Dap. This plate 
was incubated at 37° C overnight. Isolated colonies were streak purified on a new 
LB+Nal+Dap agar plate. This strain was struck on an LB+Dap plate and the WT strain 
AR060302 was struck over the top of WM3064nalR. The plate was incubated overnight. 
The resulting growth was struck onto an LB+Nal+CM+Dap plate to select for 
WM3064nalR(pAR0603020) transconjugants. This strain was used to transfer 
pAR060302 into strain DY331 in a similar manner except selection for transconjugants 
was achieved by growth on LB+Cm plates. PCR was used to amplify the neo-ccdB 
cassette from pDK45 using the primers pARdeltaTet-fw and rv (12.5 µL Phusion 2x 
master mix (Life Technologies™), 500 nM of each primer, 1 uL of template (boiled 
cells), PCR conditions: 95° C 5 min, 25 cycles of 95° C 30 sec, 55° C 30 sec, 72° C° for 
2 min; then a final incubation at 72° C for 10 min). The resulting amplicon was purified 
with a Qiagen™ PCR cleanup kit.  
  
 Strain DY331(pAR) was grown in LB+Cm broth at 32° C with shaking (200 RPM) 
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for overnight. The overnight culture was used to inoculate a new 50 mL LB+Cm broth 
culture (1:100 dilution). This was grown until an OD600 ~0.4 at which time it was 
moved to a 43° C shaking water bath and incubated for 20 min. After the incubation the 
flask was cooled on ice for 10 min. The cells were pelleted by centrifugation at 8000 
RPM for 5 min at 4° C. The cell pellet was resuspended with 25 mL ice cold H2O. The 
cells were collected again by centrifugation and washed an additional time. The final cell 
pellet was resuspended in 200 µL of ice cold H2O. A 40 µL aliquot of washed cells was 
electroporated with 0.5 – 1 µg of purified amplicon. Cells were recovered with LB broth 
and incubated at 32° C for 4 hours. After recovery cells were plated on LB+Kan plates. 
Isolated colonies were checked for growth on LB+Tet plates to confirm disruption of the 
tet(A) gene. Successful mutants were mated on LB plates with E. coli strain K-12 
MG1655 carrying pSIM5-Tet at 32° for overnight. Successful transconjugants were 
selected on LB+Cm+Tet plates. This strain was used to remove the neo-ccdB cassette by 
recombineering using a ssDNA substrate (Figure 11b) (120). Cells were primed for 
recombineering as done above and the 70 nt oligonucleotide DeltaTetRepairOligo was 
electroporated. Cells were recovered and plated on M9+Rhamnose+Tet+Cm plates. 
Isolated colonies were checked for mutations via PCR. The entire insertion-removal 
process was then done a second time in the K-12 strain to target and remove the blaCMY-2 
gene using the appropriate primers. 
  
 Deletions of predicted transcriptional regulator on pAR060302 were done 
recombineering in strain K12(pARK01, pSIM5-tet). The plasmid pKD4 carrying the 
  91 
FRT-neo-FRT cassette was used as a template for PCR (12.5 µL Phusion 2x master mix 
(Life Technologies™), 500 nM of each primer, 1 uL of template (boiled cells), PCR 
conditions: 95° C 5 min, 25 cycles of 95° C 30 sec, 55° C 30 sec, 72° C° for 2 min; then a 
final incubation at 72° C for 10 min). PCR amplicons were subjected to a DpnI digestion 
to eliminate template plasmid and then electroporated into cells primed for 
recombineering. Resulting colonies were checked by PCR for mutations. Successful 
mutants were then grown and made electrocompetent and the plasmid pCP20 was 
electroporated. These transformants were grown at 32° C for 48 hours to “flip” out the 
neo cassette, leaving a copy of FRT. The plasmid pCP20 was lost via incubation at 37° C 
for 48 hours. Colonies were screened via PCR and amplicons were verified by 
sequencing.  
  
 Molecular cloning methods. For constructs using pLUXtet, containing a 
promoterless lux operon, cloning was done via double digestion with SpeI and BamHI 
and ligation with DNA ligase. Oligonucleotides used to generate PCR amplicons of 
promoter regions with flanking ends containing restriction sites are listed in Table 6. To 
clone genes from pAR060302 into pBAD22, in vivo cloning via recomineering was used 
(117). In order to generate a template for PCR, pBAD22 was digested overnight using 
BamHI. The resulting digestion was used as template for PCR (12.5 µL Phusion 2x 
master mix (Life Technologies™), 500 nM of each primer, 1 uL of template, PCR 
conditions: 95° C 5 min, 25 cycles of 95° C 30 sec, 55° C 30 sec, 72° C° for 6 min; then a 
final incubation at 72° C for 10 min). Primers used for in vivo cloning were designed to 
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amplify the vector pBAD22, and add 40 bp regions of homology starting with 2nd codon 
of the gene of interest to the reverse primer and 40 bp of homology ending with the 
codon next to the stop codon for the forward primer. PCR amplicons were purified with a 
Qiagen™ PCR Cleanup Kit and electroporated into K12(pARK01, pSIM5-tet) cells that 
were primed for recombineering. After 4 hours of recovery in LB broth at 32° C, cells 
were plated on LB+Amp+Cm plates. Subsequent colonies were check via PCR for 
insertions in pBAD22. Successfully cloned plasmids were confirmed via DNA 
sequencing. The pSIM5-tet plasmid was lost by incubation at 37° C for 24 hours.  
  
 Conjugation experiments. E. coli strain DH10 was used as a recipient in all 
conjugation assays. Donor and recipient cells were grown overnight at 37° C in LB broth 
with the appropriate selection. The overnight cultures were used to inoculate new 5 mL 
cultures in LB broth with no selection. The new cultures were incubated for 4 hours; if 
arabinose induction was needed it was done at 2 hours of incubation. After 4 hours of 
incubation, 0.5 mL of donor and recipient cells were added to 1.5 mL centrifuge tube, 
mixed by pipetting and incubated at 37° C without shaking for 1 hour. The mating 
reactions were then vortexed and placed immediately on ice. They were subsequently 
diluted in 1x phosphate buffered saline (PBS) and plated to select for transconjugants and 
donors.  
  
 Lux reporter assays. Overnight cultures were grown with the appropriate selections 
in LB broth at 37° C with shaking (200 RPM). These cultures were diluted 1:100 in new 
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broth with selection. These cultures were grown under the same conditions for 2 hours. 
At that time, the cultures were split in half. One half was treated with arabinose (0.02%) 
and the other half received no treatment. The cultures were allowed to grow for 2 hours. 
All cultures were then aliquoted into a 96-well plate, 200 µl per well. Plates were then 
read on a Bio-Tek plate reader. Cell density and arbitrary light units were measured. 
Bioluminescence was standardized for cell density by dividing light units by the OD600 
absorbance. Each value represents the mean of 3 experiments. 
  
 RNA isolation and sequencing for RNA-Seq. Strains DH10B(pAR) and 
DH10B(pARΔacr2) were grown until an OD600 of 0.5 was achieved. Cells were pelleted 
and RNA was purified using a commercially available RNA extraction kit (Qiagen). 
Treatments were included to remove DNA contamination (Qiagen) and ribosomal RNA 
(MicrobExpress, Ambion). Two biological replicates for each strain were pooled for 
paired-end library sequencing (either 50 or 100 bp reads) via Illumina Genome Analyzer 
II at the Biomedical Genomics Center at the University of Minnesota. All of the 
sequencing data are publically available under the NCBI BioProject ID PRJNA273283. 
  
RNA-Seq Analysis. All Perl scripts and other computational biology resources 
used in this study can be found at https://github.com/kevinslang. cDNA reads were first 
trimmed so that the quality at each base position was above 30 and then mapped to the 
appropriate genome or plasmid sequence (for pAR060302, Genbank accession no. 
NC_012692, for DH10, the E. coli K-12 MG1655 published sequence was used Genbank 
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accession no. NC_000913) Read mapping was done using BOWTIE (67). For each host, 
transcriptome maps of pAR060302 were constructed using Circos (91). To achieve this, a 
table was generated containing the average number of reads mapped per 250 bp of 
plasmid sequence. Each average was then normalized per 1 million total reads in the 
cognate sequence library. These averages were then log transformed and plotted as a line 
plot. For statistical testing of differentially expressed genes, the total number of reads 
mapped to each coding sequence (CDS) was calculated using Perl. These values were 
then analyzed using the R package EdgeR (92, 93). We conservatively estimated the 
dispersion at 0.001. A fold-change cutoff of > 2 or < -2 and an adjusted p-value of < 0.05 
were used to define significantly differentially expressed genes. 
  
ChIP-Seq experiments. K12(pARK01, pBacr26xHis) was grown overnight in 
LB+Cm+Amp at 37° C with shaking (200 RPM). The overnight culture was used to 
inoculate a new 10 mL LB+Cm+Amp culture (1:100 dilution). This was grown for 2 
hours at 37° C with shaking (200 RPM). Arabinose was added to a final concentration of 
0.02% and the culture was incubated for 2 additional hours. Cells were fixed with the 
addition of formalin to a final concentration of 1%. Fixed cells were incubated at RT for 
20 min. The formalin was quenched by addition of glycine to a final concentration of 0.5 
M and incubation for 5 min at RT. Cells were collected by centrifugation at 8000 RPM 
for 5 min. The cell pellet was washed 1x with 10 mL of cold PBS and collected again. 
The resulting pellet was resuspended in 1X lysis solution (MagnaHIS Kit™, Promega). 
The cells were sonicated on ice at 5 watts for 30 second intervals and 1 min rest times. 
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This was done 10 times. The cell lysates were spun at 12,000 g for 5 min and the 
supernatant was moved to a 1.5 mL centrifuge tube containing 50 µL of MagneHIS 
particles. This suspension was taken through the MagneHIS kit protocol. After elution, 
crosslinked DNA was released via incubation at 65° C for 18 hours. The resulting DNA 
was purified with a Qiagen™ PCR Clean up Kit and sent for paired-end sequencing using 
the Illumina MiSeq platform. The library generation and sequencing was done at the 
UMGC at the University of Minnesota. In total, 2 biological replicates were sequenced 
separately. As a negative control, two genomic DNA preparations of the same cells were 
done using a Qiagen™ DNeasy™ kit and and ~400 ng of each was sent for sequencing.  
  
The reads that resulted from the MiSeq run were all trimmed to 50 bp from the 3’ 
end using the tool Trimmomatic (121). The trimmed reads were then mapped to either the 
pAR060302 sequence or the K12 genome sequence using BWA using the default 
parameters (122). Reads that were mapped correctly were filtered using SamTools (123). 
The replicate libraries were then merged using SamTools. The resulting read alignments 
files were then analyzed using MACS (110). Peak summit coordinates were used to 
extract 200 bp of sequence surrounding them using BedTools (124). These sequences 
were combined into a multifasta file and submitted to MEME for motif analysis (113). 
ChIP-Seq read alignments were also subjected to read counting on 150 bp windows of the 
pAR060302 sequence for visualization in Circos (91).  
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Protein purification and EMSA. The pBacr26xHis construct was introduced into 
strain were transformed into the BL21 (DE3) strain. The resulting strains were cultured in 
LB+AMP at 37° C for 1 hour with shaking (250 RPM). Arabinose was added to a final 
concentration of 0.2% prior to growing the cultures for 5 h at 28°C. Cells were spun at 
4500×g for 30 min, resuspended in 5 mL cell lysis buffer (20 mM Tris pH 8, 500 mM 
NaCl, 5 mM imidazole, 5 mM β-mercaptoethanol) and sonicated. The cellular debris was 
removed by centrifugation at 12,000 g for 15 min. 200 µL of MagnePURE beads were 
added to the supernatant and these were incubated for 1 h on a rocking platform, washed 
twice with high salt washing buffer (20 mM Tris pH 8, 1 M NaCl, 5 mM β-
mercaptoethanol) and twice with low salt washing buffer (20 mM Tris pH 8, 0.5 M NaCl, 
30 mM imidazole, 5 mM β-mercaptoethanol), and then eluted with 100 µL elution buffer 
(20 mM Tris pH 8, 500 mM NaCl, 500 mM imidazole). Pefabloc™ (Roche) and glycerol 
were added to final concentrations of 1 mg/mL and 5%, respectively. Purified proteins 
were analyzed by SDS-PAGE gel electrophoresis and stored at -80° C. 
 Two DNA fragments were used for EMSA analysis. The region upstream of acr1 
(~480 bp) and the floR promotor (~150 bp). These fragments were amplified by PCR 
using the primers Orf184-EMSA-F and Orf184-EMSA-R (acr1) and Flo-F and Flo-R 
(floR). The amplicons were purified using a PCR cleanup kit (Qiagen). Various 
concentrations of purified Acr2 were incubated with 10 nM DNA in binding buffer (15 
mM HEPES pH 7.9, 40 mM KCl, 1 mM EDTA, 1 mM DTT, 5% glycerol) for 30 
minutes. The reactions were separated by gel electrophoresis for 2.5 h at 70 V on a 7.5% 
native polyacrylamide gel at 4°C (buffered with Tris glycine pH 8.0). Gels were stained 
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with SYBR Green for 20 minutes at room temperature, washed twice with ddH2O, and 
DNA complexes were visualized with ultraviolet light. 
 
Figure 21. Schematic for the development of acr1-lacZ fusion reporter. a) The lacA and 
lacY genes were replaced by a FRT-neo-FRT cassette. b) The lacZ-FRT-neo-FRT 
cassette, starting with the 4th codon of lacZ, was amplified with primers adding ends 
homologous to acr1 and acaC respectively. c) This amplicon was used to replace aca1 
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(at codon 4) through acaC. d) The neo-FRT cassette was removed by introduction of 
pCP20 expressing the FLP recombinase.   
 
Development of acr1-lacZ fusion construct and detection of LacZ activity. 
Figure 21 shows the strategy for the development of the acr1-lacZ fusion. 
Recombineering was used to replace the genes lacY and lacA with an FRT-neo-FRT 
cassette (Figure 21a). The lacZ gene, starting at the 4th codon was then amplified, along 
with the FRT-neo-FRT cassette with primers that contained 40 bp of homology with acr1 
and the region upstream of acrC (Figure 21b). This amplicon was used to replace acr1-
acrC starting with the 4th codon of acr1 (Figure 21c) in strain MC4100(pARK01, pSIM5-
Tet) via recombineering and the neo-FRT cassette was removed by introduction of 
pCP20 expressing the FLP recombinase (Figure 21d). In the same strain, was disrupted 
acr2 via recombineering. These reporter cells were then transformed with constructs over 
expressing Acr2 and the relevant Acr2 variants. They were struck onto LB+Amp+Xgal 
plates with and without arabinose.    
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Chapter 5 
Discussion and future directions 
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 The work presented in this dissertation described several aspects of transcriptional 
regulation of a group of large, conjugative plasmids in Gram-negative bacteria. The 
purpose of these studies was to move beyond comparative genomics approaches to 
achieve a more in depth understanding of mechanisms contributing to plasmid 
persistence and dissemination in bacterial populations. This dissertation represents one of 
the first comprehensive attempts at better understanding the basic biology of IncA/C 
plasmids. It provides a framework and tools that can be used to design sophisticated 
experiments to better understand regulatory mechanisms encoded by IncA/C plasmids. 
 
 Studies that focus on comparative analysis of fully or partly sequenced plasmids 
have their merits. For example, the work presented in this thesis targeted a set of genes 
that are conserved amongst all IncA/C plasmids known. It is clear from comparative 
genomics analyses that IncA/C plasmids are quite dynamic and a high level of 
conservation implies functional importance. The drawback of comparative genomics is 
that such conclusions assume that genes are expressed and/or are functional. It is possible 
that this is not the case. Additionally, for IncA/C plasmids in particular, many genes 
simply cannot be assigned a function during annotation due to the lack of similarity with 
genes of known function. In this case, comparative genomics sheds little insight into the 
biological role of such genes. Coupling high throughput genome sequencing, comparative 
analyses and functional molecular genetics is necessary to provide a deep understanding 
of how poorly annotated genes might be contributing to plasmid carriage or spread. 
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 Using RNA-Seq, we mapped the transcriptome of pAR060302 under antimicrobial 
selection and when carried by different host bacteria. We were able to understand what 
genes are expressed under laboratory conditions and also gained insight into what 
mechanisms encoded on the host bacterial chromosome might play important roles in the 
carriage of IncA/C plasmids.  We used that information to further inform more specific 
experiments. After developing mutants of genes of interest we were able to piece together 
part of the regulatory network responsible for regulating conjugation of IncA/C plasmids. 
 
 Modern genetic techniques nearly all rely on the introduction of resistance genes to 
select for mutations, whether they be generated by PCR or delivered by a phage or 
transposon. The systematic genetic study of something that confers resistance to nearly 
every class of antimicrobials was a difficult task to overcome. It is no wonder that, in 
parallel, another lab developed an IncA/C variant with fewer resistance genes in order to 
design sophisticated experiments (19). The only difference between their experimental 
system and the one developed for this work is that pARK01 was made using precise 
mutations of specific resistance genes. The other IncA/C variant was made by an 
unknown deletion, which resulted in a plasmid variant nearly identical to other IncA/C 
plasmids, but missing an unknown portion of DNA. Still, this dissertation, as well as the 
work of Carraro et al., show the huge potential of coupling high throughput techniques, 
like RNA-Seq and ChIP-Seq, with more traditional molecular genetics approaches (35). 
Detailed experiments such as these will be necessary to understand the myriad of 
hypothetical proteins encoded on IncA/C plasmids.  
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 The future for work focused on characterizing IncA/C plasmids is wide open. 
Certainly, genome-plasmid crosstalk should be pursued in more detail. Chapter 3 of this 
dissertation attempted to better understand these processes. A drawback to the design of 
those experiments was the use of bacterial hosts with unfished and poorly annotated 
genomes. We attempted to take a comparative transcriptomics approach, which provided 
a myriad of questions and no answers. Fortuitously, the modulation of 2-carbon 
metabolism in E. coli emerged as a result of Chapter 3 and then came up again in Chapter 
4 as a target of Acr2. These results could be used as a direction for future work. A key 
first step could be simple growth experiments comparing E. coli strain K-12 strain with 
and without plasmid pARK01 in M9 minimal media using glycolate as the sole carbon 
source. A plasmid variant carrying an acr2 mutation could also be used to further explore 
the possibility of direct regulation by Acr2. Further work should include the potential for 
induction of the glc operon by Acr2. The chromosomal factor IHF has previously been 
shown to positively regulate this operon (125). Precisely how 2-carbon metabolism might 
provide a fitness advantage in the broader context of IncA/C plasmid acquisition and 
carriage is a complex question, but specific alteration of host metabolic pathways by 
plasmid encoded factors suggests that it is important.  
 
 Whether or not IncA/C plasmid transfer can be induced by environmental or host 
cues is another area worth pursuing. This has been studied in enormous detail in the Ti 
and pCF10 plasmid systems (126, 127). The R27 plasmid has also been shown to sense 
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temperature (108). As detailed in Chapter 4 of this dissertation, the closely related SXT 
elements have a phage-like gene setR that encodes a repressor that is susceptible to RecA 
mediated degradation. IncA/C plasmids don’t encode a homolog of SetR and their 
transfer is not dependent on recA (19). Given the number of factors contributing to the 
repression of IncA/C conjugation it would be logical that it be up-regulated by some 
mechanism. From the knowledge and tools developed in this dissertation, experiments 
can be carried out to expand the model for the regulation of IncA/C conjugation. For 
example, it is now known that IncA/C conjugation is dependent on acaDC expression. 
Using the acr1-lacZ fusion plasmid described in Chapter 4, a suitable screen could be 
carried out to look for mutants with increased LacZ activity that would lead to candidate 
mechanisms. Couple this experiment with a high throughput approach such as Tn-Seq 
and one could imagine a situation where the model of regulation might expand very 
rapidly (128).  
  
 One area completely unexplored in IncA/C plasmids are the role of small RNAs or 
small, non-annotated, proteins in the regulation of plasmid mechanisms. Our 
transcriptome mapping experiments in Chapter 2 first identified the possibility that 
IncA/C plasmids might express small RNAs or small peptides. This concept is certainly 
not new to plasmid biology, but given the diversity and complexity of previously 
described systems, it would be worthwhile to explore (126, 129). 
 
 The proposed experiments above are only a few directions future work could take 
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and only concern data generated in this dissertation. There are many more 
uncharacterized genes carried by IncA/C plasmids that are waiting to be explored. It 
would be prudent to study these hypothetical proteins not only for the insight it would 
provide to IncA/C biology, but also, given their evolutionary distance from proteins with 
known function, it would potentially produce new functional categories of proteins. 
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Appendex A 
Summary of experimental evolution experiments using 
A/C plasmid containing strains.  
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IncA/C gene content is more unstable over time when acr2 . We evolved E. coli K-12 
and Salmonella Newport carrying pAR060302 and pAR060302Δacr2 over 50 days by 
passing the strains in LB broth cultures. Each strain was used to inoculate a 5 mL LB 
aliquot and was grown at 37° C overnight with shaking (200 RPM). Every day, 50 µL of 
the overnight culture was used to inoculate a new 5 mL culture. Every 10 days, 750 µL of 
the overnight growth was frozen at -80° C with a 20% final concentration of glycerol. 
The 50 day cultures were allowed to thaw on ice and 100 µL was taken and added to 100 
µL of fresh LB. These were grown at 37° C with shaking (200 RPM). After 4 hours, the 
cultures were serially diluted out to 10-8 in PBS and plated on LB plates. Individual 
colonies were picked and patched onto a 48 spot grid on a new LB plate. After 24 hour 
incubation, a 48 prong plate replicator was used to replica plate the spots onto LB, 
LB+TET, LB+CM and LB+AMP plates. For K12, 470 colonies were picked and for 
Salmonella Newport, 235 colonies were picked. Numbers of susceptible colonies were 
counted. If susceptible result was unclear, the spot was re-struck onto a new LB plate 
containing the appropriate antibiotic. 
 
Table 7. Susceptible colonies of E. coli K12 carrying either pAR060302 or 
pAR060302Δacr2 after passing 50 days in LB with no antibiotic selection. 
  pAR060302 pAR060302Δacr2 
Chloramphenicol  236 62 
Tetracycline  239 64 
Ampicillin  1 61 
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Table 8. Susceptible colonies of Salmonella Newport carrying either pAR060302 or 
pAR060302Δacr2 after passing 50 days in LB with no antibiotic selection. 
  pAR060302 pAR060302Δacr2 
Chloramphenicol  1 235 
Tetracycline  11 235 
Ampicillin  126 235 
 
Our results indicate that the floR-tet(A) cassette is more unstable in the WT plasmid 
versus the acr2 mutant when carried by K12 (Table 7). Conversely, this cassette is 
relatively stable in S. Newport (Table 8). In K-12, we found that the blaCMY-2 gene is less 
stable in the acr2 mutant. None of the ampicillin susceptible colonies were susceptible to 
any other antibiotic, except in S. Newport(pAR060302Δacr2), where it seems the entire 
plasmid seems to be unstable. To test this, PCR targeting the repA gene on pAR060302 
was done on 5 randomly selected ampicillin susceptible colonies of S. Newport 
(pAR060302Δacr2). All colonies were negative, suggesting complete plasmid loss. In K-
12 (pAR060302Δacr2), 3 of the ampicillin susceptible colonies were selected and PCR 
targeting 15 genes was conducted. These PCR results suggest that a large mutation 
occurred that excised the entire Tra1 locus. Out of the 3 colonies selected it appears there 
are at least 2 separate lineages of deletions because spot 3 contains ORF68 whereas the 
other spots do not (Table 9).  
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Table 9. PCR results of 3 ampicillin susceptible colonies of K-12 (pAR060302Δacr2). 
Gene Colony 1 Colony 2 Colony 3 Gene Colony 1 Colony 2 Colony 3 
ORF55 + + + ORF99 - - - 
ORF68 - - + ORF104 - - - 
traI - - - ORF111 - - - 
traD - - - ORF111 - - - 
ORF75 - - - ORF126 - - - 
traV - - - tn3 - - - 
blaCMY-2 - - - int1 - - - 
ORF88 - - - groSEL + + + 
 
The phenotypic results of the E. coli evolution experiments first suggested that Acr2 
binding to the ISEcp1 locus might have aided its stability over time. After closer 
examination using PCR, as well as the results of the same experiment in S. Newport it 
seems that this might not necessarily be the case. If acr2 is deleted, this would result in a 
subsequent up-regulation of acaDC, which would in turn up-regulate the transfer genes. 
Having the transfer genes up-regulated would likely be costly to those cells giving a 
predictable advantage to cells that can achieve a large deletion. The same result would be 
expected in Salmonella. However, we did not observe this. We observed total plasmid 
loss. One possible explanation is that in Salmonella, up-regulation of acaDC not only up-
regulates the transfer genes, but also up-regulates genes on genomic islands (35). This 
might increase the fitness cost of carrying such a plasmid above some threshold where 
the barrier of the various stability mechanisms (psk and par) can be overcome. These 
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results suggest that there are different fitness outcomes for mutations occurring on the 
plasmid that are dependent on host chromosomal gene content. If there are more 
interactions between the plasmid and host chromosome, then that would select for a 
stable plasmid sequence. This would suggest that A/C plasmids might interact with the 
host chromosome much more than previously thought, despite their broad host-range. 
This interplay between the host chromosome and A/C plasmids might account for the 
relatively low number of mutations observed on the A/C backbone between different 
fully sequenced plasmids.   
